Frequencies for first 10,000 rows of pt variable in reac2017q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abasia | 9 0.09 0.09 Abdominal adhesions | 1 0.01 0.10 Abdominal discomfort | 16 0.16 0.26 Abdominal distension | 7 0.07 0.33 Abdominal infection | 1 0.01 0.34 Abdominal mass | 1 0.01 0.35 Abdominal pain | 39 0.39 0.74 Abdominal pain lower | 4 0.04 0.78 Abdominal pain upper | 17 0.17 0.95 Abdominal sepsis | 1 0.01 0.96 Abdominal tenderness | 1 0.01 0.97 Abdominal wall disorder | 1 0.01 0.98 Abdominoplasty | 1 0.01 0.99 Abnormal behaviour | 6 0.06 1.05 Abnormal dreams | 5 0.05 1.10 Abnormal faeces | 3 0.03 1.13 Abnormal loss of weight | 1 0.01 1.14 Abnormal sensation in eye | 2 0.02 1.16 Abnormal weight gain | 2 0.02 1.18 Abortion | 1 0.01 1.19 Abortion induced | 2 0.02 1.21 Abortion missed | 1 0.01 1.22 Abortion spontaneous | 8 0.08 1.30 Abscess | 3 0.03 1.33 Accident | 4 0.04 1.37 Accidental exposure to product | 3 0.03 1.40 Accidental overdose | 1 0.01 1.41 Acidosis | 2 0.02 1.43 Acne | 9 0.09 1.52 Acne cystic | 1 0.01 1.53 Acquired immunodeficiency syndrome | 1 0.01 1.54 Acquired mixed hyperlipidaemia | 1 0.01 1.55 Acrochordon | 1 0.01 1.56 Activities of daily living impaired | 7 0.07 1.63 Acute coronary syndrome | 2 0.02 1.65 Acute disseminated encephalomyelitis | 1 0.01 1.66 Acute hepatic failure | 2 0.02 1.68 Acute hepatitis B | 1 0.01 1.69 Acute kidney injury | 24 0.24 1.93 Acute megakaryocytic leukaemia | 1 0.01 1.94 Acute myeloid leukaemia | 14 0.14 2.08 Acute myocardial infarction | 9 0.09 2.17 Acute pulmonary oedema | 4 0.04 2.21 Acute respiratory distress syndrome | 2 0.02 2.23 Acute respiratory failure | 3 0.03 2.26 Acute sinusitis | 2 0.02 2.28 Adenocarcinoma | 1 0.01 2.29 Adenocarcinoma gastric | 1 0.01 2.30 Adenocarcinoma of colon | 3 0.03 2.33 Adenocarcinoma pancreas | 1 0.01 2.34 Adenoid cystic carcinoma | 1 0.01 2.35 Adenoidal disorder | 1 0.01 2.36 Adenoidectomy | 1 0.01 2.37 Adenotonsillectomy | 1 0.01 2.38 Adenoviral upper respiratory infection | 1 0.01 2.39 Adjustment disorder | 1 0.01 2.40 Adjustment disorder with depressed mood | 1 0.01 2.41 Adjustment disorder with mixed anxiet.. | 1 0.01 2.42 Adnexa uteri mass | 1 0.01 2.43 Adrenal adenoma | 1 0.01 2.44 Adrenal disorder | 1 0.01 2.45 Adrenal insufficiency | 2 0.02 2.47 Adrenal suppression | 1 0.01 2.48 Adverse drug reaction | 7 0.07 2.55 Adverse event | 19 0.19 2.74 Adverse reaction | 2 0.02 2.76 Affect lability | 3 0.03 2.79 Aggression | 7 0.07 2.86 Agitation | 10 0.10 2.96 Agranulocytosis | 4 0.04 3.00 Akathisia | 2 0.02 3.02 Akinesia | 1 0.01 3.03 Alanine aminotransferase abnormal | 1 0.01 3.04 Alanine aminotransferase increased | 11 0.11 3.15 Alcohol abuse | 2 0.02 3.17 Alcohol poisoning | 1 0.01 3.18 Alcoholism | 1 0.01 3.19 Allergy to chemicals | 1 0.01 3.20 Alopecia | 25 0.25 3.45 Alpha 1 foetoprotein increased | 1 0.01 3.46 Altered state of consciousness | 4 0.04 3.50 Alveolitis allergic | 1 0.01 3.51 Amenorrhoea | 1 0.01 3.52 Amnesia | 18 0.18 3.70 Amniotic cavity infection | 1 0.01 3.71 Amylase increased | 1 0.01 3.72 Amyloidosis | 2 0.02 3.74 Anaemia | 68 0.68 4.42 Anaemia of chronic disease | 2 0.02 4.44 Anaemia of malignant disease | 1 0.01 4.45 Anaemia postoperative | 9 0.09 4.54 Anaemia vitamin B12 deficiency | 1 0.01 4.55 Anal abscess | 1 0.01 4.56 Anal fissure | 1 0.01 4.57 Anal fistula | 2 0.02 4.59 Anal haemorrhage | 2 0.02 4.61 Anal incontinence | 3 0.03 4.64 Anaphylactic reaction | 3 0.03 4.67 Anaphylactic shock | 5 0.05 4.72 Anastomotic stenosis | 1 0.01 4.73 Anastomotic ulcer | 1 0.01 4.74 Androgen deficiency | 3 0.03 4.77 Androgens abnormal | 1 0.01 4.78 Aneurysm | 1 0.01 4.79 Anger | 1 0.01 4.80 Angina pectoris | 9 0.09 4.89 Angina unstable | 3 0.03 4.92 Angioedema | 5 0.05 4.97 Angiopathy | 3 0.03 5.00 Angle closure glaucoma | 1 0.01 5.01 Anhedonia | 1 0.01 5.02 Animal bite | 1 0.01 5.03 Ankle brachial index | 1 0.01 5.04 Ankle deformity | 1 0.01 5.05 Ankle fracture | 12 0.12 5.17 Anogenital warts | 1 0.01 5.18 Anorectal discomfort | 1 0.01 5.19 Anorectal disorder | 1 0.01 5.20 Anorectal infection | 1 0.01 5.21 Anticonvulsant drug level decreased | 1 0.01 5.22 Anticonvulsant drug level increased | 1 0.01 5.23 Antinuclear antibody increased | 1 0.01 5.24 Antinuclear antibody positive | 1 0.01 5.25 Antiphospholipid syndrome | 1 0.01 5.26 Anuria | 1 0.01 5.27 Anxiety | 61 0.61 5.88 Anxiety disorder | 1 0.01 5.89 Aortic aneurysm | 1 0.01 5.90 Aortic calcification | 2 0.02 5.92 Aortic stenosis | 2 0.02 5.94 Aortic valve calcification | 1 0.01 5.95 Aortic valve incompetence | 1 0.01 5.96 Aortic valve replacement | 1 0.01 5.97 Aortic valve sclerosis | 1 0.01 5.98 Aortic valve stenosis | 1 0.01 5.99 Apallic syndrome | 1 0.01 6.00 Apathy | 1 0.01 6.01 Aphasia | 1 0.01 6.02 Aphonia | 3 0.03 6.05 Aphthous ulcer | 4 0.04 6.09 Apnoea | 2 0.02 6.11 Apparent death | 2 0.02 6.13 Appendicectomy | 8 0.08 6.21 Appendicitis | 1 0.01 6.22 Appendix disorder | 1 0.01 6.23 Appetite disorder | 1 0.01 6.24 Application site erythema | 1 0.01 6.25 Application site infection | 1 0.01 6.26 Application site pain | 1 0.01 6.27 Application site scar | 1 0.01 6.28 Arnold-Chiari malformation | 1 0.01 6.29 Arrhythmia | 13 0.13 6.42 Arterial injury | 1 0.01 6.43 Arterial occlusive disease | 3 0.03 6.46 Arterial stenosis | 1 0.01 6.47 Arterial thrombosis | 1 0.01 6.48 Arteriosclerosis | 5 0.05 6.53 Arteriosclerosis coronary artery | 1 0.01 6.54 Arteriospasm coronary | 1 0.01 6.55 Arthralgia | 77 0.77 7.32 Arthritis | 25 0.25 7.57 Arthritis bacterial | 2 0.02 7.59 Arthritis infective | 1 0.01 7.60 Arthropathy | 21 0.21 7.81 Arthroscopy | 1 0.01 7.82 Articular calcification | 1 0.01 7.83 Artificial crown procedure | 1 0.01 7.84 Ascites | 8 0.08 7.92 Aspartate aminotransferase abnormal | 2 0.02 7.94 Aspartate aminotransferase increased | 9 0.09 8.03 Asphyxia | 3 0.03 8.06 Aspiration | 1 0.01 8.07 Aspiration bronchial | 1 0.01 8.08 Aspiration pleural cavity | 2 0.02 8.10 Asthenia | 35 0.35 8.45 Asthenopia | 1 0.01 8.46 Asthma | 23 0.23 8.69 Astrocytoma, low grade | 1 0.01 8.70 Ataxia | 1 0.01 8.71 Atelectasis | 7 0.07 8.78 Atrial fibrillation | 17 0.17 8.95 Atrial septal defect | 3 0.03 8.98 Atrial tachycardia | 1 0.01 8.99 Atrioventricular block complete | 2 0.02 9.01 Atrioventricular block first degree | 2 0.02 9.03 Atrioventricular block second degree | 1 0.01 9.04 Atrophic vulvovaginitis | 1 0.01 9.05 Attention deficit/hyperactivity disor.. | 2 0.02 9.07 Atypical femur fracture | 4 0.04 9.11 Atypical pneumonia | 1 0.01 9.12 Auditory disorder | 1 0.01 9.13 Autism | 1 0.01 9.14 Autism spectrum disorder | 1 0.01 9.15 Autoantibody positive | 1 0.01 9.16 Autoimmune disorder | 1 0.01 9.17 Autoimmune haemolytic anaemia | 1 0.01 9.18 Autonomic nervous system imbalance | 1 0.01 9.19 Autonomic neuropathy | 1 0.01 9.20 Azoospermia | 1 0.01 9.21 B-cell lymphoma | 2 0.02 9.23 B-lymphocyte count decreased | 1 0.01 9.24 B-lymphocyte count increased | 1 0.01 9.25 Back disorder | 4 0.04 9.29 Back injury | 1 0.01 9.30 Back pain | 49 0.49 9.79 Bacterial infection | 4 0.04 9.83 Bacteroides bacteraemia | 1 0.01 9.84 Balance disorder | 10 0.10 9.94 Barotrauma | 1 0.01 9.95 Barrett's oesophagus | 4 0.04 9.99 Basal cell carcinoma | 7 0.07 10.06 Bedridden | 2 0.02 10.08 Benign bone neoplasm | 1 0.01 10.09 Benign breast neoplasm | 3 0.03 10.12 Benign neoplasm | 2 0.02 10.14 Benign prostatic hyperplasia | 2 0.02 10.16 Beta 2 microglobulin urine increased | 1 0.01 10.17 Beta haemolytic streptococcal infection | 1 0.01 10.18 Beta-N-acetyl-D-glucosaminidase incre.. | 1 0.01 10.19 Bicuspid aortic valve | 2 0.02 10.21 Bile duct stenosis | 1 0.01 10.22 Bile duct stone | 3 0.03 10.25 Biliary dilatation | 2 0.02 10.27 Biopsy | 1 0.01 10.28 Biopsy bone | 2 0.02 10.30 Biopsy breast | 1 0.01 10.31 Bipolar I disorder | 1 0.01 10.32 Bipolar disorder | 6 0.06 10.38 Bite | 1 0.01 10.39 Bladder cancer | 1 0.01 10.40 Bladder cancer recurrent | 1 0.01 10.41 Bladder dilatation | 1 0.01 10.42 Bladder disorder | 3 0.03 10.45 Bladder dysfunction | 1 0.01 10.46 Bladder hypertrophy | 1 0.01 10.47 Bladder injury | 1 0.01 10.48 Bladder outlet obstruction | 1 0.01 10.49 Bladder papilloma | 1 0.01 10.50 Bladder prolapse | 1 0.01 10.51 Bladder transitional cell carcinoma | 1 0.01 10.52 Blepharitis | 2 0.02 10.54 Blepharospasm | 1 0.01 10.55 Blindness | 8 0.08 10.63 Blindness unilateral | 3 0.03 10.66 Blister | 7 0.07 10.73 Blood albumin decreased | 3 0.03 10.76 Blood aldosterone increased | 1 0.01 10.77 Blood alkaline phosphatase increased | 5 0.05 10.82 Blood antidiuretic hormone increased | 1 0.01 10.83 Blood bilirubin increased | 6 0.06 10.89 Blood calcium increased | 1 0.01 10.90 Blood cholesterol | 1 0.01 10.91 Blood cholesterol abnormal | 4 0.04 10.95 Blood cholesterol increased | 26 0.26 11.21 Blood chromium increased | 1 0.01 11.22 Blood chromogranin A increased | 1 0.01 11.23 Blood corticotrophin decreased | 1 0.01 11.24 Blood cortisol decreased | 1 0.01 11.25 Blood creatine phosphokinase increased | 3 0.03 11.28 Blood creatinine abnormal | 1 0.01 11.29 Blood creatinine increased | 13 0.13 11.42 Blood disorder | 1 0.01 11.43 Blood gases abnormal | 1 0.01 11.44 Blood glucose abnormal | 2 0.02 11.46 Blood glucose decreased | 4 0.04 11.50 Blood glucose increased | 18 0.18 11.68 Blood growth hormone increased | 1 0.01 11.69 Blood heavy metal increased | 1 0.01 11.70 Blood iron decreased | 2 0.02 11.72 Blood lactate dehydrogenase abnormal | 1 0.01 11.73 Blood lactate dehydrogenase increased | 5 0.05 11.78 Blood lactic acid increased | 1 0.01 11.79 Blood parathyroid hormone increased | 1 0.01 11.80 Blood phosphorus increased | 1 0.01 11.81 Blood potassium decreased | 8 0.08 11.89 Blood potassium increased | 3 0.03 11.92 Blood pressure abnormal | 4 0.04 11.96 Blood pressure decreased | 8 0.08 12.04 Blood pressure diastolic decreased | 3 0.03 12.07 Blood pressure diastolic increased | 1 0.01 12.08 Blood pressure fluctuation | 7 0.07 12.15 Blood pressure immeasurable | 1 0.01 12.16 Blood pressure increased | 19 0.19 12.35 Blood pressure systolic decreased | 1 0.01 12.36 Blood pressure systolic increased | 12 0.12 12.48 Blood prolactin abnormal | 1 0.01 12.49 Blood sodium decreased | 5 0.05 12.54 Blood test abnormal | 1 0.01 12.55 Blood testosterone decreased | 5 0.05 12.60 Blood thyroid stimulating hormone inc.. | 1 0.01 12.61 Blood triglycerides increased | 7 0.07 12.68 Blood urea increased | 3 0.03 12.71 Blood urine present | 4 0.04 12.75 Body height abnormal | 1 0.01 12.76 Body height decreased | 11 0.11 12.87 Body mass index increased | 1 0.01 12.88 Body temperature decreased | 7 0.07 12.95 Body temperature fluctuation | 2 0.02 12.97 Body temperature increased | 1 0.01 12.98 Body tinea | 1 0.01 12.99 Bone cancer | 2 0.02 13.01 Bone contusion | 1 0.01 13.02 Bone deformity | 1 0.01 13.03 Bone density decreased | 2 0.02 13.05 Bone development abnormal | 1 0.01 13.06 Bone disorder | 6 0.06 13.12 Bone graft | 4 0.04 13.16 Bone loss | 4 0.04 13.20 Bone marrow failure | 2 0.02 13.22 Bone marrow toxicity | 1 0.01 13.23 Bone marrow transplant rejection | 1 0.01 13.24 Bone operation | 1 0.01 13.25 Bone pain | 8 0.08 13.33 Bradycardia | 7 0.07 13.40 Bradyphrenia | 1 0.01 13.41 Brain contusion | 1 0.01 13.42 Brain herniation | 1 0.01 13.43 Brain injury | 4 0.04 13.47 Brain neoplasm | 3 0.03 13.50 Brain neoplasm malignant | 1 0.01 13.51 Brain oedema | 2 0.02 13.53 Brain stem haemorrhage | 1 0.01 13.54 Breast abscess | 1 0.01 13.55 Breast cancer | 5 0.05 13.60 Breast cancer female | 4 0.04 13.64 Breast cancer metastatic | 2 0.02 13.66 Breast cancer stage I | 1 0.01 13.67 Breast conserving surgery | 1 0.01 13.68 Breast cyst | 3 0.03 13.71 Breast cyst excision | 1 0.01 13.72 Breast disorder | 2 0.02 13.74 Breast enlargement | 1 0.01 13.75 Breast hyperplasia | 1 0.01 13.76 Breast mass | 2 0.02 13.78 Breast necrosis | 1 0.01 13.79 Breast neoplasm | 1 0.01 13.80 Breast pain | 1 0.01 13.81 Bronchiolitis | 1 0.01 13.82 Bronchitis | 20 0.20 14.02 Bronchitis chronic | 1 0.01 14.03 Bronchopneumopathy | 1 0.01 14.04 Bronchopulmonary aspergillosis | 3 0.03 14.07 Bronchospasm | 3 0.03 14.10 Bruxism | 1 0.01 14.11 Bundle branch block left | 1 0.01 14.12 Bundle branch block right | 4 0.04 14.16 Burning sensation | 4 0.04 14.20 Bursa disorder | 1 0.01 14.21 Bursitis | 11 0.11 14.32 Bursitis infective | 1 0.01 14.33 Butterfly rash | 1 0.01 14.34 C-reactive protein increased | 6 0.06 14.40 CD4 lymphocytes decreased | 1 0.01 14.41 CSF immunoglobulin increased | 1 0.01 14.42 Cachexia | 1 0.01 14.43 Calcification of muscle | 1 0.01 14.44 Calcium deficiency | 3 0.03 14.47 Calculus urinary | 1 0.01 14.48 Candida infection | 8 0.08 14.56 Candida sepsis | 1 0.01 14.57 Carcinoembryonic antigen | 1 0.01 14.58 Carcinoid syndrome | 1 0.01 14.59 Cardiac aneurysm | 2 0.02 14.61 Cardiac arrest | 6 0.06 14.67 Cardiac disorder | 22 0.22 14.89 Cardiac failure | 20 0.20 15.09 Cardiac failure acute | 1 0.01 15.10 Cardiac failure congestive | 12 0.12 15.22 Cardiac flutter | 1 0.01 15.23 Cardiac murmur | 3 0.03 15.26 Cardiac operation | 1 0.01 15.27 Cardiac pacemaker battery replacement | 1 0.01 15.28 Cardiac pacemaker insertion | 3 0.03 15.31 Cardiac stress test abnormal | 1 0.01 15.32 Cardiac valve disease | 4 0.04 15.36 Cardiac ventricular disorder | 1 0.01 15.37 Cardio-respiratory arrest | 3 0.03 15.40 Cardiolipin antibody positive | 1 0.01 15.41 Cardiomegaly | 3 0.03 15.44 Cardiomyopathy | 3 0.03 15.47 Cardiotoxicity | 2 0.02 15.49 Cardiovascular disorder | 4 0.04 15.53 Cardiovascular symptom | 1 0.01 15.54 Carotid arteriosclerosis | 2 0.02 15.56 Carotid artery bypass | 1 0.01 15.57 Carotid artery calcification | 1 0.01 15.58 Carotid artery disease | 1 0.01 15.59 Carotid artery occlusion | 3 0.03 15.62 Carotid artery stenosis | 3 0.03 15.65 Carotid pulse | 1 0.01 15.66 Carpal tunnel decompression | 3 0.03 15.69 Carpal tunnel syndrome | 7 0.07 15.76 Cartilage atrophy | 1 0.01 15.77 Cataract | 20 0.20 15.97 Cataract operation | 6 0.06 16.03 Catheter site erythema | 1 0.01 16.04 Catheter site pruritus | 1 0.01 16.05 Catheterisation cardiac | 3 0.03 16.08 Cell death | 1 0.01 16.09 Cellulitis | 16 0.16 16.25 Central nervous system haemorrhage | 1 0.01 16.26 Central nervous system infection | 1 0.01 16.27 Central nervous system lesion | 5 0.05 16.32 Central obesity | 1 0.01 16.33 Central venous catheterisation | 1 0.01 16.34 Cerebellar haemorrhage | 1 0.01 16.35 Cerebral artery thrombosis | 1 0.01 16.36 Cerebral atrophy | 2 0.02 16.38 Cerebral disorder | 9 0.09 16.47 Cerebral haemorrhage | 10 0.10 16.57 Cerebral infarction | 12 0.12 16.69 Cerebral ischaemia | 2 0.02 16.71 Cerebral thrombosis | 1 0.01 16.72 Cerebral venous thrombosis | 1 0.01 16.73 Cerebrovascular accident | 32 0.32 17.05 Cerebrovascular insufficiency | 1 0.01 17.06 Cervical dysplasia | 1 0.01 17.07 Cervical polypectomy | 1 0.01 17.08 Cervical radiculopathy | 2 0.02 17.10 Cervical vertebral fracture | 2 0.02 17.12 Cervix carcinoma | 2 0.02 17.14 Chalazion | 2 0.02 17.16 Chapped lips | 1 0.01 17.17 Chemotherapy | 1 0.01 17.18 Chest discomfort | 14 0.14 17.32 Chest injury | 2 0.02 17.34 Chest pain | 25 0.25 17.59 Chills | 9 0.09 17.68 Choking | 3 0.03 17.71 Choking sensation | 2 0.02 17.73 Cholangiocarcinoma | 1 0.01 17.74 Cholangitis | 1 0.01 17.75 Cholecystectomy | 5 0.05 17.80 Cholecystitis | 1 0.01 17.81 Cholecystitis acute | 2 0.02 17.83 Cholecystitis infective | 1 0.01 17.84 Cholelithiasis | 15 0.15 17.99 Cholestasis | 1 0.01 18.00 Chondrocalcinosis pyrophosphate | 1 0.01 18.01 Chondromalacia | 1 0.01 18.02 Choroidal detachment | 2 0.02 18.04 Chromaturia | 1 0.01 18.05 Chromosomal deletion | 1 0.01 18.06 Chronic fatigue syndrome | 1 0.01 18.07 Chronic gastritis | 2 0.02 18.09 Chronic kidney disease | 4 0.04 18.13 Chronic lymphocytic leukaemia | 2 0.02 18.15 Chronic myeloid leukaemia | 1 0.01 18.16 Chronic obstructive pulmonary disease | 12 0.12 18.28 Chronic respiratory failure | 1 0.01 18.29 Chronic sinusitis | 2 0.02 18.31 Chronic spontaneous urticaria | 2 0.02 18.33 Circulatory collapse | 2 0.02 18.35 Circumstance or information capable o.. | 6 0.06 18.41 Clavicle fracture | 1 0.01 18.42 Closed fracture manipulation | 1 0.01 18.43 Clostridium difficile colitis | 3 0.03 18.46 Coagulopathy | 2 0.02 18.48 Coarctation of the aorta | 1 0.01 18.49 Coeliac disease | 1 0.01 18.50 Cognitive disorder | 30 0.30 18.80 Cold sweat | 1 0.01 18.81 Colectomy | 1 0.01 18.82 Colitis | 12 0.12 18.94 Colitis ischaemic | 2 0.02 18.96 Colitis microscopic | 1 0.01 18.97 Colitis ulcerative | 2 0.02 18.99 Collagen disorder | 1 0.01 19.00 Colon adenoma | 2 0.02 19.02 Colon cancer | 5 0.05 19.07 Colon cancer metastatic | 3 0.03 19.10 Colon cancer recurrent | 2 0.02 19.12 Colon operation | 1 0.01 19.13 Colonoscopy | 1 0.01 19.14 Colorectal cancer metastatic | 1 0.01 19.15 Coma | 5 0.05 19.20 Coma scale abnormal | 1 0.01 19.21 Combined pulmonary fibrosis and emphy.. | 1 0.01 19.22 Communication disorder | 2 0.02 19.24 Completed suicide | 4 0.04 19.28 Complex partial seizures | 1 0.01 19.29 Complex regional pain syndrome | 1 0.01 19.30 Complication associated with device | 4 0.04 19.34 Compression fracture | 7 0.07 19.41 Computerised tomogram abnormal | 1 0.01 19.42 Concomitant disease aggravated | 2 0.02 19.44 Concomitant disease progression | 1 0.01 19.45 Concussion | 3 0.03 19.48 Condition aggravated | 20 0.20 19.68 Confusional state | 19 0.19 19.87 Congenital anomaly | 1 0.01 19.88 Congenital central nervous system ano.. | 1 0.01 19.89 Congenital cerebral cyst | 1 0.01 19.90 Congenital oral malformation | 1 0.01 19.91 Congenital teratoma | 1 0.01 19.92 Congenital urethral anomaly | 1 0.01 19.93 Congestive cardiomyopathy | 1 0.01 19.94 Conjunctival haemorrhage | 2 0.02 19.96 Conjunctival hyperaemia | 1 0.01 19.97 Conjunctivitis | 2 0.02 19.99 Conjunctivitis allergic | 1 0.01 20.00 Connective tissue disorder | 2 0.02 20.02 Constipation | 32 0.32 20.34 Contraindicated product administered | 1 0.01 20.35 Contusion | 17 0.17 20.52 Coordination abnormal | 3 0.03 20.55 Corneal erosion | 1 0.01 20.56 Coronary angioplasty | 1 0.01 20.57 Coronary arterial stent insertion | 1 0.01 20.58 Coronary artery bypass | 3 0.03 20.61 Coronary artery disease | 10 0.10 20.71 Coronary artery occlusion | 2 0.02 20.73 Coronary artery restenosis | 1 0.01 20.74 Coronary artery stenosis | 2 0.02 20.76 Costochondritis | 1 0.01 20.77 Cough | 37 0.37 21.14 Craniocerebral injury | 3 0.03 21.17 Creatinine renal clearance decreased | 2 0.02 21.19 Crohn's disease | 4 0.04 21.23 Crying | 4 0.04 21.27 Cryptococcosis | 1 0.01 21.28 Cushing's syndrome | 3 0.03 21.31 Cushingoid | 2 0.02 21.33 Cyanopsia | 1 0.01 21.34 Cyanosis | 1 0.01 21.35 Cyst | 6 0.06 21.41 Cyst removal | 2 0.02 21.43 Cystic fibrosis | 1 0.01 21.44 Cystitis | 7 0.07 21.51 Cystitis interstitial | 2 0.02 21.53 Cystocele | 1 0.01 21.54 Cystopexy | 1 0.01 21.55 Cytogenetic abnormality | 1 0.01 21.56 Cytogenetic analysis abnormal | 1 0.01 21.57 Cytokine release syndrome | 1 0.01 21.58 Cytomegalovirus enterocolitis | 2 0.02 21.60 Cytomegalovirus infection | 2 0.02 21.62 Cytomegalovirus viraemia | 1 0.01 21.63 Cytopenia | 3 0.03 21.66 Dandruff | 1 0.01 21.67 Daydreaming | 1 0.01 21.68 Deafness | 4 0.04 21.72 Deafness neurosensory | 4 0.04 21.76 Death | 48 0.48 22.24 Decreased activity | 1 0.01 22.25 Decreased appetite | 31 0.31 22.56 Decreased immune responsiveness | 1 0.01 22.57 Decreased interest | 2 0.02 22.59 Decubitus ulcer | 2 0.02 22.61 Deep vein thrombosis | 22 0.22 22.83 Dehydration | 29 0.29 23.12 Deja vu | 1 0.01 23.13 Delirium | 5 0.05 23.18 Dementia | 8 0.08 23.26 Dementia Alzheimer's type | 2 0.02 23.28 Dengue fever | 1 0.01 23.29 Dental caries | 3 0.03 23.32 Dental implantation | 2 0.02 23.34 Dental prosthesis placement | 1 0.01 23.35 Depressed level of consciousness | 5 0.05 23.40 Depressed mood | 12 0.12 23.52 Depression | 65 0.65 24.17 Dermatitis | 5 0.05 24.22 Dermatitis allergic | 1 0.01 24.23 Dermatitis atopic | 1 0.01 24.24 Dermatitis contact | 2 0.02 24.26 Dermatitis diaper | 1 0.01 24.27 Dermatitis exfoliative | 1 0.01 24.28 Dermatitis exfoliative generalised | 1 0.01 24.29 Dermatitis infected | 1 0.01 24.30 Dermatomyositis | 1 0.01 24.31 Dermatophytosis of nail | 1 0.01 24.32 Developmental delay | 2 0.02 24.34 Device breakage | 2 0.02 24.36 Device deployment issue | 1 0.01 24.37 Device difficult to use | 1 0.01 24.38 Device dislocation | 2 0.02 24.40 Device expulsion | 1 0.01 24.41 Device failure | 5 0.05 24.46 Device issue | 3 0.03 24.49 Device leakage | 1 0.01 24.50 Device loosening | 1 0.01 24.51 Device malfunction | 6 0.06 24.57 Device occlusion | 1 0.01 24.58 Device related infection | 7 0.07 24.65 Device use issue | 1 0.01 24.66 Diabetes mellitus | 26 0.26 24.92 Diabetes mellitus inadequate control | 3 0.03 24.95 Diabetic neuropathy | 4 0.04 24.99 Diabetic retinopathy | 2 0.02 25.01 Dialysis | 2 0.02 25.03 Diaphragmatic disorder | 1 0.01 25.04 Diaphragmatic hernia | 1 0.01 25.05 Diarrhoea | 99 0.99 26.04 Diffuse large B-cell lymphoma | 1 0.01 26.05 Diffuse panbronchiolitis | 1 0.01 26.06 Diplopia | 3 0.03 26.09 Disability | 1 0.01 26.10 Discomfort | 5 0.05 26.15 Disease complication | 1 0.01 26.16 Disease progression | 8 0.08 26.24 Disorientation | 4 0.04 26.28 Disseminated intravascular coagulation | 8 0.08 26.36 Disseminated tuberculosis | 1 0.01 26.37 Disturbance in attention | 6 0.06 26.43 Disturbance in sexual arousal | 1 0.01 26.44 Diverticular perforation | 1 0.01 26.45 Diverticulitis | 9 0.09 26.54 Diverticulitis intestinal haemorrhagic | 1 0.01 26.55 Diverticulum | 6 0.06 26.61 Diverticulum intestinal | 3 0.03 26.64 Diverticulum intestinal haemorrhagic | 1 0.01 26.65 Dizziness | 52 0.52 27.17 Dizziness postural | 2 0.02 27.19 Double ureter | 1 0.01 27.20 Drooling | 3 0.03 27.23 Drug abuse | 6 0.06 27.29 Drug abuser | 1 0.01 27.30 Drug administered to patient of inapp.. | 1 0.01 27.31 Drug administration error | 4 0.04 27.35 Drug dependence | 4 0.04 27.39 Drug diversion | 1 0.01 27.40 Drug dose omission | 56 0.56 27.96 Drug effect decreased | 7 0.07 28.03 Drug effect incomplete | 6 0.06 28.09 Drug effect increased | 1 0.01 28.10 Drug eruption | 2 0.02 28.12 Drug hypersensitivity | 63 0.63 28.75 Drug ineffective | 81 0.81 29.56 Drug ineffective for unapproved indic.. | 12 0.12 29.68 Drug interaction | 14 0.14 29.82 Drug intolerance | 12 0.12 29.94 Drug level above therapeutic | 1 0.01 29.95 Drug level decreased | 1 0.01 29.96 Drug level increased | 4 0.04 30.00 Drug prescribing error | 2 0.02 30.02 Drug reaction with eosinophilia and s.. | 4 0.04 30.06 Drug resistance | 4 0.04 30.10 Drug therapeutic incompatibility | 1 0.01 30.11 Drug tolerance | 4 0.04 30.15 Drug withdrawal convulsions | 1 0.01 30.16 Drug withdrawal syndrome | 4 0.04 30.20 Drug-induced liver injury | 3 0.03 30.23 Dry eye | 11 0.11 30.34 Dry mouth | 12 0.12 30.46 Dry skin | 5 0.05 30.51 Dry throat | 1 0.01 30.52 Duodenal ulcer | 2 0.02 30.54 Dysaesthesia | 1 0.01 30.55 Dysarthria | 5 0.05 30.60 Dysgeusia | 4 0.04 30.64 Dysgraphia | 4 0.04 30.68 Dyskinesia | 5 0.05 30.73 Dyslexia | 1 0.01 30.74 Dyslipidaemia | 5 0.05 30.79 Dysmenorrhoea | 1 0.01 30.80 Dysmorphism | 1 0.01 30.81 Dyspepsia | 29 0.29 31.10 Dysphagia | 15 0.15 31.25 Dysphemia | 3 0.03 31.28 Dysphonia | 7 0.07 31.35 Dysphoria | 1 0.01 31.36 Dyspnoea | 95 0.95 32.31 Dyspnoea exertional | 6 0.06 32.37 Dyspraxia | 1 0.01 32.38 Dysstasia | 2 0.02 32.40 Dystonia | 1 0.01 32.41 Dysuria | 4 0.04 32.45 Ear discomfort | 1 0.01 32.46 Ear infection | 4 0.04 32.50 Ear pain | 2 0.02 32.52 Eastern Cooperative Oncology Group pe.. | 1 0.01 32.53 Eating disorder | 6 0.06 32.59 Ecchymosis | 1 0.01 32.60 Eczema | 5 0.05 32.65 Eczema nummular | 1 0.01 32.66 Educational problem | 1 0.01 32.67 Effusion | 1 0.01 32.68 Ejaculation disorder | 5 0.05 32.73 Ejaculation failure | 6 0.06 32.79 Ejection fraction abnormal | 1 0.01 32.80 Ejection fraction decreased | 4 0.04 32.84 Elbow deformity | 1 0.01 32.85 Elbow operation | 1 0.01 32.86 Electrocardiogram QT prolonged | 8 0.08 32.94 Electrocardiogram ST segment elevation | 3 0.03 32.97 Electrocardiogram abnormal | 4 0.04 33.01 Electrocardiogram change | 1 0.01 33.02 Electrocution | 1 0.01 33.03 Electroencephalogram abnormal | 1 0.01 33.04 Electrolyte imbalance | 3 0.03 33.07 Embolism | 3 0.03 33.10 Embolism venous | 1 0.01 33.11 Emergency care examination | 1 0.01 33.12 Emotional disorder | 8 0.08 33.20 Emotional distress | 5 0.05 33.25 Emotional poverty | 1 0.01 33.26 Emphysema | 4 0.04 33.30 Empyema | 2 0.02 33.32 Encephalitis | 1 0.01 33.33 Encephalitis viral | 1 0.01 33.34 Encephalopathy | 3 0.03 33.37 End stage renal disease | 3 0.03 33.40 Endocardial disease | 1 0.01 33.41 Endocrine disorder | 2 0.02 33.43 Endodontic procedure | 2 0.02 33.45 Endometrial adenocarcinoma | 1 0.01 33.46 Endometrial cancer | 1 0.01 33.47 Endophthalmitis | 2 0.02 33.49 Endoscopic retrograde cholangiopancre.. | 1 0.01 33.50 Endotracheal intubation | 2 0.02 33.52 Enterococcal bacteraemia | 1 0.01 33.53 Enterocolitis | 2 0.02 33.55 Enterocolitis haemorrhagic | 1 0.01 33.56 Enterostomy | 1 0.01 33.57 Enuresis | 1 0.01 33.58 Enzyme abnormality | 1 0.01 33.59 Enzyme level abnormal | 1 0.01 33.60 Eosinophil count increased | 1 0.01 33.61 Eosinophilia | 1 0.01 33.62 Eosinophilic pneumonia | 1 0.01 33.63 Epicondylitis | 1 0.01 33.64 Epidermal naevus | 1 0.01 33.65 Epidermolysis | 1 0.01 33.66 Epididymal cyst | 1 0.01 33.67 Epididymitis | 2 0.02 33.69 Epilepsy | 5 0.05 33.74 Episcleritis | 1 0.01 33.75 Epistaxis | 14 0.14 33.89 Epstein-Barr virus infection | 1 0.01 33.90 Erectile dysfunction | 33 0.33 34.23 Erosive oesophagitis | 1 0.01 34.24 Eructation | 6 0.06 34.30 Erythema | 17 0.17 34.47 Erythema multiforme | 1 0.01 34.48 Erythema nodosum | 1 0.01 34.49 Erythema of eyelid | 1 0.01 34.50 Escherichia bacteraemia | 1 0.01 34.51 Escherichia infection | 3 0.03 34.54 Escherichia test positive | 1 0.01 34.55 Escherichia urinary tract infection | 1 0.01 34.56 Essential hypertension | 4 0.04 34.60 Essential thrombocythaemia | 1 0.01 34.61 Euphoric mood | 2 0.02 34.63 Eustachian tube dysfunction | 1 0.01 34.64 Ewing's sarcoma | 1 0.01 34.65 Exaggerated startle response | 1 0.01 34.66 Excoriation | 1 0.01 34.67 Exercise tolerance decreased | 6 0.06 34.73 Exfoliative rash | 1 0.01 34.74 Exostosis | 5 0.05 34.79 Expanded disability status scale scor.. | 2 0.02 34.81 Expired product administered | 2 0.02 34.83 Exposed bone in jaw | 2 0.02 34.85 Exposure during pregnancy | 12 0.12 34.97 Exposure to violent event | 1 0.01 34.98 Exposure via father | 2 0.02 35.00 Extra dose administered | 4 0.04 35.04 Extrapyramidal disorder | 1 0.01 35.05 Extrasystoles | 4 0.04 35.09 Eye contusion | 1 0.01 35.10 Eye discharge | 1 0.01 35.11 Eye disorder | 1 0.01 35.12 Eye haemorrhage | 1 0.01 35.13 Eye infection | 2 0.02 35.15 Eye infection viral | 1 0.01 35.16 Eye irritation | 2 0.02 35.18 Eye oedema | 1 0.01 35.19 Eye operation | 2 0.02 35.21 Eye operation complication | 1 0.01 35.22 Eye pain | 7 0.07 35.29 Eye pruritus | 1 0.01 35.30 Eye swelling | 2 0.02 35.32 Eyelid cyst | 2 0.02 35.34 Eyelid infection | 1 0.01 35.35 Eyelid oedema | 3 0.03 35.38 Eyelid operation | 1 0.01 35.39 Eyelid ptosis | 2 0.02 35.41 Face injury | 1 0.01 35.42 Facial asymmetry | 1 0.01 35.43 Facial bones fracture | 3 0.03 35.46 Facial paralysis | 3 0.03 35.49 Facial paresis | 2 0.02 35.51 Factor IX inhibition | 1 0.01 35.52 Faecaloma | 4 0.04 35.56 Faeces discoloured | 1 0.01 35.57 Faeces pale | 1 0.01 35.58 Faeces soft | 2 0.02 35.60 Fall | 82 0.82 36.42 Fanconi syndrome | 1 0.01 36.43 Fatigue | 105 1.05 37.48 Fear | 8 0.08 37.56 Febrile bone marrow aplasia | 6 0.06 37.62 Febrile neutropenia | 30 0.30 37.92 Feeding disorder | 4 0.04 37.96 Feeling abnormal | 28 0.28 38.24 Feeling cold | 3 0.03 38.27 Feeling hot | 4 0.04 38.31 Feeling jittery | 1 0.01 38.32 Felty's syndrome | 1 0.01 38.33 Femoral hernia | 1 0.01 38.34 Femoral neck fracture | 6 0.06 38.40 Femoroacetabular impingement | 1 0.01 38.41 Femur fracture | 53 0.53 38.94 Fibromyalgia | 8 0.08 39.02 Fibula fracture | 5 0.05 39.07 Finger deformity | 1 0.01 39.08 Fistula | 2 0.02 39.10 Flank pain | 3 0.03 39.13 Flat affect | 1 0.01 39.14 Flatulence | 10 0.10 39.24 Fluid intake reduced | 1 0.01 39.25 Fluid overload | 1 0.01 39.26 Fluid retention | 9 0.09 39.35 Flushing | 11 0.11 39.46 Foaming at mouth | 1 0.01 39.47 Focal nodular hyperplasia | 1 0.01 39.48 Foetal exposure during pregnancy | 13 0.13 39.61 Folliculitis | 2 0.02 39.63 Food allergy | 2 0.02 39.65 Food craving | 1 0.01 39.66 Food poisoning | 2 0.02 39.68 Foot deformity | 6 0.06 39.74 Foot fracture | 12 0.12 39.86 Foot operation | 2 0.02 39.88 Forced expiratory volume abnormal | 1 0.01 39.89 Foreign body | 1 0.01 39.90 Foreign body sensation in eyes | 1 0.01 39.91 Fracture | 4 0.04 39.95 Fracture delayed union | 4 0.04 39.99 Fracture nonunion | 9 0.09 40.08 Fractured ischium | 3 0.03 40.11 Frequent bowel movements | 1 0.01 40.12 Frustration tolerance decreased | 5 0.05 40.17 Full blood count decreased | 1 0.01 40.18 Functional gastrointestinal disorder | 2 0.02 40.20 Fungaemia | 1 0.01 40.21 Fungal infection | 6 0.06 40.27 Fungal skin infection | 2 0.02 40.29 Furuncle | 1 0.01 40.30 Gait disturbance | 44 0.44 40.74 Galactorrhoea | 1 0.01 40.75 Gallbladder disorder | 4 0.04 40.79 Gallbladder enlargement | 1 0.01 40.80 Gallbladder polyp | 1 0.01 40.81 Gamma-glutamyltransferase increased | 3 0.03 40.84 Gangrene | 3 0.03 40.87 Gastric cancer | 2 0.02 40.89 Gastric dilatation | 2 0.02 40.91 Gastric disorder | 4 0.04 40.95 Gastric haemorrhage | 1 0.01 40.96 Gastric operation | 1 0.01 40.97 Gastric pH decreased | 1 0.01 40.98 Gastric perforation | 1 0.01 40.99 Gastric polyps | 2 0.02 41.01 Gastric ulcer | 10 0.10 41.11 Gastric varices haemorrhage | 1 0.01 41.12 Gastritis | 5 0.05 41.17 Gastritis erosive | 1 0.01 41.18 Gastroenteritis | 4 0.04 41.22 Gastroenteritis viral | 3 0.03 41.25 Gastrointestinal candidiasis | 1 0.01 41.26 Gastrointestinal disorder | 11 0.11 41.37 Gastrointestinal haemorrhage | 19 0.19 41.56 Gastrointestinal hypomotility | 1 0.01 41.57 Gastrointestinal infection | 2 0.02 41.59 Gastrointestinal inflammation | 1 0.01 41.60 Gastrointestinal necrosis | 2 0.02 41.62 Gastrointestinal neoplasm | 2 0.02 41.64 Gastrointestinal pain | 1 0.01 41.65 Gastrointestinal perforation | 3 0.03 41.68 Gastrointestinal sounds abnormal | 1 0.01 41.69 Gastrointestinal stoma complication | 1 0.01 41.70 Gastrointestinal stromal tumour | 3 0.03 41.73 Gastrointestinal toxicity | 4 0.04 41.77 Gastrointestinal tract irritation | 1 0.01 41.78 Gastrointestinal tract mucosal discol.. | 1 0.01 41.79 Gastrointestinal viral infection | 1 0.01 41.80 Gastrooesophageal reflux disease | 47 0.47 42.27 Gene mutation | 1 0.01 42.28 Gene mutation identification test pos.. | 1 0.01 42.29 General physical health deterioration | 16 0.16 42.45 General symptom | 1 0.01 42.46 Generalised anxiety disorder | 2 0.02 42.48 Generalised oedema | 5 0.05 42.53 Generalised tonic-clonic seizure | 1 0.01 42.54 Genital haemorrhage | 1 0.01 42.55 Genital hypoaesthesia | 2 0.02 42.57 Genital lesion | 1 0.01 42.58 Germ cell neoplasm | 1 0.01 42.59 Gilbert's syndrome | 1 0.01 42.60 Gingival bleeding | 3 0.03 42.63 Gingival disorder | 3 0.03 42.66 Gingival erythema | 1 0.01 42.67 Gingival pain | 1 0.01 42.68 Gingivitis | 2 0.02 42.70 Gingivitis ulcerative | 1 0.01 42.71 Glaucoma | 11 0.11 42.82 Glioblastoma | 1 0.01 42.83 Gliosis | 1 0.01 42.84 Glomerular filtration rate abnormal | 1 0.01 42.85 Glomerular filtration rate decreased | 1 0.01 42.86 Glomerulonephritis | 1 0.01 42.87 Glossitis | 1 0.01 42.88 Glucose tolerance impaired | 3 0.03 42.91 Glycosylated haemoglobin increased | 2 0.02 42.93 Gout | 3 0.03 42.96 Granulocytopenia | 2 0.02 42.98 Granuloma | 1 0.01 42.99 Grip strength decreased | 1 0.01 43.00 Groin pain | 3 0.03 43.03 Gun shot wound | 1 0.01 43.04 Gynaecomastia | 6 0.06 43.10 H1N1 influenza | 1 0.01 43.11 HELLP syndrome | 1 0.01 43.12 HLA marker study positive | 1 0.01 43.13 Haemangioma | 1 0.01 43.14 Haemangioma removal | 1 0.01 43.15 Haemarthrosis | 2 0.02 43.17 Haematemesis | 3 0.03 43.20 Haematochezia | 2 0.02 43.22 Haematocrit abnormal | 1 0.01 43.23 Haematocrit decreased | 5 0.05 43.28 Haematoma | 7 0.07 43.35 Haematoma evacuation | 1 0.01 43.36 Haematospermia | 1 0.01 43.37 Haematuria | 6 0.06 43.43 Haemodialysis | 1 0.01 43.44 Haemoglobin abnormal | 1 0.01 43.45 Haemoglobin decreased | 14 0.14 43.59 Haemolysis | 2 0.02 43.61 Haemolytic uraemic syndrome | 4 0.04 43.65 Haemoptysis | 4 0.04 43.69 Haemorrhage | 13 0.13 43.82 Haemorrhage intracranial | 1 0.01 43.83 Haemorrhage subcutaneous | 2 0.02 43.85 Haemorrhage urinary tract | 1 0.01 43.86 Haemorrhagic anaemia | 7 0.07 43.93 Haemorrhagic diathesis | 1 0.01 43.94 Haemorrhagic stroke | 1 0.01 43.95 Haemorrhoidal haemorrhage | 3 0.03 43.98 Haemorrhoids | 5 0.05 44.03 Hair disorder | 1 0.01 44.04 Hair texture abnormal | 1 0.01 44.05 Hallucination | 7 0.07 44.12 Hallucination, visual | 1 0.01 44.13 Hallucinations, mixed | 1 0.01 44.14 Hand deformity | 1 0.01 44.15 Hand fracture | 3 0.03 44.18 Hand-foot-and-mouth disease | 1 0.01 44.19 Hangover | 1 0.01 44.20 Head banging | 1 0.01 44.21 Head discomfort | 5 0.05 44.26 Head injury | 7 0.07 44.33 Headache | 66 0.66 44.99 Hearing disability | 1 0.01 45.00 Heart disease congenital | 2 0.02 45.02 Heart rate decreased | 3 0.03 45.05 Heart rate increased | 6 0.06 45.11 Heart rate irregular | 2 0.02 45.13 Heart valve incompetence | 1 0.01 45.14 Heat stroke | 1 0.01 45.15 Helicobacter infection | 1 0.01 45.16 Helicobacter test positive | 2 0.02 45.18 Hemiparesis | 8 0.08 45.26 Hemiplegia | 1 0.01 45.27 Hemivertebra | 1 0.01 45.28 Henoch-Schonlein purpura | 1 0.01 45.29 Hepatic atrophy | 2 0.02 45.31 Hepatic cancer | 1 0.01 45.32 Hepatic cancer metastatic | 1 0.01 45.33 Hepatic cirrhosis | 7 0.07 45.40 Hepatic congestion | 1 0.01 45.41 Hepatic cyst | 2 0.02 45.43 Hepatic dysplasia | 1 0.01 45.44 Hepatic encephalopathy | 2 0.02 45.46 Hepatic enzyme abnormal | 1 0.01 45.47 Hepatic enzyme increased | 12 0.12 45.59 Hepatic failure | 12 0.12 45.71 Hepatic function abnormal | 12 0.12 45.83 Hepatic lesion | 1 0.01 45.84 Hepatic neoplasm | 5 0.05 45.89 Hepatic steatosis | 5 0.05 45.94 Hepatic vein thrombosis | 1 0.01 45.95 Hepatitis | 1 0.01 45.96 Hepatitis B | 2 0.02 45.98 Hepatitis C | 5 0.05 46.03 Hepatitis C virus test positive | 1 0.01 46.04 Hepatitis cholestatic | 2 0.02 46.06 Hepatobiliary disease | 1 0.01 46.07 Hepatocellular carcinoma | 2 0.02 46.09 Hepatocellular injury | 2 0.02 46.11 Hepatomegaly | 2 0.02 46.13 Hepatotoxicity | 4 0.04 46.17 Hernia | 8 0.08 46.25 Hernia repair | 1 0.01 46.26 Herpes simplex | 2 0.02 46.28 Herpes virus infection | 4 0.04 46.32 Herpes zoster | 16 0.16 46.48 Hiatus hernia | 7 0.07 46.55 Hiccups | 3 0.03 46.58 High density lipoprotein decreased | 1 0.01 46.59 High density lipoprotein increased | 1 0.01 46.60 Hip arthroplasty | 11 0.11 46.71 Hip fracture | 8 0.08 46.79 Hip surgery | 3 0.03 46.82 Histiocytosis haematophagic | 2 0.02 46.84 Hodgkin's disease | 1 0.01 46.85 Homicidal ideation | 1 0.01 46.86 Homicide | 1 0.01 46.87 Hordeolum | 1 0.01 46.88 Hormone level abnormal | 2 0.02 46.90 Hospitalisation | 7 0.07 46.97 Hot flush | 5 0.05 47.02 Human polyomavirus infection | 1 0.01 47.03 Humerus fracture | 6 0.06 47.09 Hunger | 2 0.02 47.11 Hydrocephalus | 3 0.03 47.14 Hydronephrosis | 2 0.02 47.16 Hyperaesthesia | 2 0.02 47.18 Hyperammonaemia | 1 0.01 47.19 Hyperbilirubinaemia | 6 0.06 47.25 Hypercalcaemia | 5 0.05 47.30 Hypercalciuria | 1 0.01 47.31 Hypercholesterolaemia | 9 0.09 47.40 Hyperemesis gravidarum | 1 0.01 47.41 Hyperglycaemia | 20 0.20 47.61 Hyperhidrosis | 9 0.09 47.70 Hyperkalaemia | 4 0.04 47.74 Hyperkeratosis | 1 0.01 47.75 Hyperkinesia | 1 0.01 47.76 Hyperlipidaemia | 10 0.10 47.86 Hypernatraemia | 1 0.01 47.87 Hyperparathyroidism | 2 0.02 47.89 Hyperphagia | 1 0.01 47.90 Hyperphosphatasaemia | 1 0.01 47.91 Hyperprolactinaemia | 1 0.01 47.92 Hyperreflexia | 1 0.01 47.93 Hypersensitivity | 26 0.26 48.19 Hypersomnia | 2 0.02 48.21 Hypertension | 68 0.68 48.89 Hypertensive crisis | 2 0.02 48.91 Hypertonia | 1 0.01 48.92 Hypertonic bladder | 1 0.01 48.93 Hypertransaminasaemia | 1 0.01 48.94 Hypertrichosis | 1 0.01 48.95 Hyperuricaemia | 2 0.02 48.97 Hypoacusis | 12 0.12 49.09 Hypoaesthesia | 27 0.27 49.36 Hypoaesthesia oral | 1 0.01 49.37 Hypoalbuminaemia | 2 0.02 49.39 Hypocalcaemia | 6 0.06 49.45 Hypochloraemia | 1 0.01 49.46 Hypocoagulable state | 1 0.01 49.47 Hypogammaglobulinaemia | 2 0.02 49.49 Hypoglycaemia | 10 0.10 49.59 Hypogonadism | 3 0.03 49.62 Hypogonadism male | 3 0.03 49.65 Hypokalaemia | 18 0.18 49.83 Hypokinesia | 6 0.06 49.89 Hypomagnesaemia | 2 0.02 49.91 Hyponatraemia | 17 0.17 50.08 Hypophagia | 4 0.04 50.12 Hypophosphataemia | 5 0.05 50.17 Hypopituitarism | 1 0.01 50.18 Hypopnoea | 1 0.01 50.19 Hypoproteinaemia | 1 0.01 50.20 Hyporeflexia | 1 0.01 50.21 Hyposmia | 1 0.01 50.22 Hypospadias | 1 0.01 50.23 Hypotension | 20 0.20 50.43 Hypothermia | 1 0.01 50.44 Hypothyroidism | 10 0.10 50.54 Hypotonia | 2 0.02 50.56 Hypotonic urinary bladder | 1 0.01 50.57 Hypovolaemia | 1 0.01 50.58 Hypoxia | 2 0.02 50.60 Hypoxic-ischaemic encephalopathy | 1 0.01 50.61 Hysterectomy | 5 0.05 50.66 IIIrd nerve paralysis | 1 0.01 50.67 Idiopathic interstitial pneumonia | 1 0.01 50.68 Idiopathic pulmonary fibrosis | 1 0.01 50.69 Ileostomy | 1 0.01 50.70 Ileus | 3 0.03 50.73 Ileus paralytic | 1 0.01 50.74 Iliac artery occlusion | 1 0.01 50.75 Ilium fracture | 1 0.01 50.76 Ill-defined disorder | 7 0.07 50.83 Immune reconstitution inflammatory sy.. | 3 0.03 50.86 Immune system disorder | 3 0.03 50.89 Immune thrombocytopenic purpura | 1 0.01 50.90 Immunodeficiency | 2 0.02 50.92 Immunoglobulins decreased | 1 0.01 50.93 Immunosuppressant drug level increased | 1 0.01 50.94 Immunosuppression | 4 0.04 50.98 Impaired driving ability | 2 0.02 51.00 Impaired gastric emptying | 3 0.03 51.03 Impaired healing | 11 0.11 51.14 Impaired self-care | 2 0.02 51.16 Impaired work ability | 3 0.03 51.19 Implant site erythema | 1 0.01 51.20 Inability to afford medication | 1 0.01 51.21 Inappropriate antidiuretic hormone se.. | 6 0.06 51.27 Inappropriate schedule of drug admini.. | 33 0.33 51.60 Incision site complication | 1 0.01 51.61 Incision site haematoma | 1 0.01 51.62 Incision site haemorrhage | 1 0.01 51.63 Incisional hernia | 1 0.01 51.64 Incontinence | 3 0.03 51.67 Incorrect dose administered | 9 0.09 51.76 Incorrect drug administration duration | 3 0.03 51.79 Incorrect product storage | 4 0.04 51.83 Incorrect route of drug administration | 1 0.01 51.84 Increased appetite | 3 0.03 51.87 Increased tendency to bruise | 4 0.04 51.91 Induced labour | 1 0.01 51.92 Infarction | 2 0.02 51.94 Infection | 36 0.36 52.30 Infectious pleural effusion | 1 0.01 52.31 Infective exacerbation of chronic obs.. | 1 0.01 52.32 Inferior vena cava syndrome | 1 0.01 52.33 Infestation | 1 0.01 52.34 Inflammation | 5 0.05 52.39 Inflammatory bowel disease | 2 0.02 52.41 Influenza | 27 0.27 52.68 Influenza like illness | 7 0.07 52.75 Infrequent bowel movements | 1 0.01 52.76 Infusion | 1 0.01 52.77 Infusion related reaction | 11 0.11 52.88 Infusion site extravasation | 1 0.01 52.89 Infusion site haemorrhage | 1 0.01 52.90 Infusion site pain | 2 0.02 52.92 Ingrowing nail | 1 0.01 52.93 Inguinal hernia | 6 0.06 52.99 Inguinal hernia repair | 2 0.02 53.01 Inhibitory drug interaction | 1 0.01 53.02 Injection site bruising | 6 0.06 53.08 Injection site cellulitis | 1 0.01 53.09 Injection site discolouration | 1 0.01 53.10 Injection site erythema | 7 0.07 53.17 Injection site extravasation | 1 0.01 53.18 Injection site haemorrhage | 3 0.03 53.21 Injection site induration | 1 0.01 53.22 Injection site inflammation | 2 0.02 53.24 Injection site mass | 2 0.02 53.26 Injection site nodule | 2 0.02 53.28 Injection site pain | 20 0.20 53.48 Injection site papule | 2 0.02 53.50 Injection site pruritus | 3 0.03 53.53 Injection site rash | 1 0.01 53.54 Injection site reaction | 6 0.06 53.60 Injection site scab | 1 0.01 53.61 Injection site swelling | 5 0.05 53.66 Injection site urticaria | 1 0.01 53.67 Injection site warmth | 3 0.03 53.70 Injury | 11 0.11 53.81 Injury associated with device | 2 0.02 53.83 Inner ear disorder | 2 0.02 53.85 Insomnia | 49 0.49 54.34 Inspiratory capacity decreased | 1 0.01 54.35 Insulin resistance | 2 0.02 54.37 Insulin-like growth factor decreased | 1 0.01 54.38 Insulin-like growth factor increased | 1 0.01 54.39 Insulin-requiring type 2 diabetes mel.. | 1 0.01 54.40 Insulinoma | 1 0.01 54.41 Intentional device misuse | 1 0.01 54.42 Intentional overdose | 5 0.05 54.47 Intentional product misuse | 36 0.36 54.83 Intentional product use issue | 7 0.07 54.90 Intentional self-injury | 2 0.02 54.92 Intermittent claudication | 1 0.01 54.93 Intermittent explosive disorder | 1 0.01 54.94 Internal fixation of fracture | 4 0.04 54.98 Internal haemorrhage | 1 0.01 54.99 International normalised ratio abnormal | 1 0.01 55.00 International normalised ratio decrea.. | 1 0.01 55.01 International normalised ratio increa.. | 4 0.04 55.05 Interstitial lung disease | 16 0.16 55.21 Intervertebral disc compression | 1 0.01 55.22 Intervertebral disc degeneration | 11 0.11 55.33 Intervertebral disc disorder | 3 0.03 55.36 Intervertebral disc displacement | 1 0.01 55.37 Intervertebral disc protrusion | 15 0.15 55.52 Intervertebral disc space narrowing | 1 0.01 55.53 Intervertebral discitis | 1 0.01 55.54 Intestinal dilatation | 2 0.02 55.56 Intestinal haemorrhage | 1 0.01 55.57 Intestinal infarction | 1 0.01 55.58 Intestinal ischaemia | 1 0.01 55.59 Intestinal obstruction | 6 0.06 55.65 Intestinal perforation | 4 0.04 55.69 Intestinal polyp | 1 0.01 55.70 Intestinal sepsis | 1 0.01 55.71 Intra-abdominal haemorrhage | 2 0.02 55.73 Intramedullary rod insertion | 20 0.20 55.93 Intraocular lens implant | 2 0.02 55.95 Intraocular pressure increased | 2 0.02 55.97 Intrauterine infection | 1 0.01 55.98 Invasive ductal breast carcinoma | 4 0.04 56.02 Iodine overload | 1 0.01 56.03 Iris atrophy | 1 0.01 56.04 Iris transillumination defect | 1 0.01 56.05 Iron deficiency anaemia | 2 0.02 56.07 Irritability | 12 0.12 56.19 Irritable bowel syndrome | 6 0.06 56.25 Ischaemia | 1 0.01 56.26 Ischaemic cardiomyopathy | 2 0.02 56.28 Ischaemic stroke | 2 0.02 56.30 Itching scar | 1 0.01 56.31 JC virus infection | 1 0.01 56.32 JC virus test positive | 1 0.01 56.33 Jaundice | 3 0.03 56.36 Jaundice cholestatic | 1 0.01 56.37 Jaw fracture | 3 0.03 56.40 Joint arthroplasty | 1 0.01 56.41 Joint crepitation | 2 0.02 56.43 Joint destruction | 1 0.01 56.44 Joint dislocation | 6 0.06 56.50 Joint dislocation reduction | 3 0.03 56.53 Joint effusion | 7 0.07 56.60 Joint injury | 6 0.06 56.66 Joint stiffness | 2 0.02 56.68 Joint swelling | 11 0.11 56.79 Jugular vein thrombosis | 1 0.01 56.80 Juvenile idiopathic arthritis | 1 0.01 56.81 K-ras gene mutation | 1 0.01 56.82 Keratomileusis | 1 0.01 56.83 Keratopathy | 1 0.01 56.84 Kidney infection | 5 0.05 56.89 Knee arthroplasty | 8 0.08 56.97 Knee operation | 3 0.03 57.00 Kyphoscoliosis | 1 0.01 57.01 Kyphosis | 1 0.01 57.02 Labelled drug-drug interaction medica.. | 1 0.01 57.03 Labile blood pressure | 1 0.01 57.04 Labile hypertension | 1 0.01 57.05 Laboratory test abnormal | 1 0.01 57.06 Labyrinthitis | 2 0.02 57.08 Laceration | 6 0.06 57.14 Lacrimal duct procedure | 1 0.01 57.15 Lacrimation increased | 3 0.03 57.18 Lacunar infarction | 1 0.01 57.19 Lagophthalmos | 1 0.01 57.20 Large intestinal obstruction | 1 0.01 57.21 Large intestinal polypectomy | 1 0.01 57.22 Large intestinal ulcer haemorrhage | 1 0.01 57.23 Large intestine erosion | 1 0.01 57.24 Large intestine perforation | 2 0.02 57.26 Large intestine polyp | 3 0.03 57.29 Laryngeal pain | 2 0.02 57.31 Laryngitis | 1 0.01 57.32 Laziness | 1 0.01 57.33 Left ventricular dysfunction | 3 0.03 57.36 Left ventricular failure | 2 0.02 57.38 Left ventricular hypertrophy | 2 0.02 57.40 Lethargy | 6 0.06 57.46 Leukaemia | 3 0.03 57.49 Leukaemia recurrent | 1 0.01 57.50 Leukocytosis | 4 0.04 57.54 Leukoencephalopathy | 1 0.01 57.55 Leukopenia | 20 0.20 57.75 Libido decreased | 18 0.18 57.93 Libido disorder | 1 0.01 57.94 Lichen sclerosus | 1 0.01 57.95 Ligament injury | 3 0.03 57.98 Ligament operation | 2 0.02 58.00 Ligament rupture | 1 0.01 58.01 Ligament sprain | 1 0.01 58.02 Limb asymmetry | 4 0.04 58.06 Limb deformity | 2 0.02 58.08 Limb discomfort | 8 0.08 58.16 Limb injury | 9 0.09 58.25 Limb mass | 1 0.01 58.26 Limb operation | 3 0.03 58.29 Lip dry | 1 0.01 58.30 Lip exfoliation | 1 0.01 58.31 Lip infection | 1 0.01 58.32 Lip injury | 1 0.01 58.33 Lip oedema | 1 0.01 58.34 Lip pain | 1 0.01 58.35 Lip swelling | 2 0.02 58.37 Lip ulceration | 1 0.01 58.38 Lipase increased | 2 0.02 58.40 Lipids increased | 2 0.02 58.42 Lipodystrophy acquired | 1 0.01 58.43 Lipoma | 2 0.02 58.45 Listless | 1 0.01 58.46 Livedo reticularis | 1 0.01 58.47 Liver abscess | 1 0.01 58.48 Liver disorder | 8 0.08 58.56 Liver function test abnormal | 2 0.02 58.58 Liver function test increased | 7 0.07 58.65 Liver transplant | 1 0.01 58.66 Lobular breast carcinoma in situ | 1 0.01 58.67 Localised infection | 9 0.09 58.76 Loose body in joint | 1 0.01 58.77 Loss of consciousness | 15 0.15 58.92 Loss of control of legs | 1 0.01 58.93 Loss of libido | 9 0.09 59.02 Low birth weight baby | 2 0.02 59.04 Low density lipoprotein abnormal | 1 0.01 59.05 Low density lipoprotein increased | 1 0.01 59.06 Low turnover osteopathy | 37 0.37 59.43 Lower gastrointestinal haemorrhage | 1 0.01 59.44 Lower limb fracture | 3 0.03 59.47 Lower respiratory tract infection | 5 0.05 59.52 Lumbar radiculopathy | 5 0.05 59.57 Lumbar spinal stenosis | 4 0.04 59.61 Lumbar vertebral fracture | 1 0.01 59.62 Lumbosacral radiculopathy | 2 0.02 59.64 Lung adenocarcinoma | 1 0.01 59.65 Lung disorder | 13 0.13 59.78 Lung infection | 4 0.04 59.82 Lung infiltration | 1 0.01 59.83 Lung neoplasm malignant | 6 0.06 59.89 Lung transplant | 1 0.01 59.90 Lupus-like syndrome | 1 0.01 59.91 Lyme disease | 1 0.01 59.92 Lymphadenectomy | 1 0.01 59.93 Lymphadenitis | 1 0.01 59.94 Lymphadenopathy | 6 0.06 60.00 Lymphatic disorder | 1 0.01 60.01 Lymphocele | 1 0.01 60.02 Lymphocyte count decreased | 11 0.11 60.13 Lymphocytic leukaemia | 1 0.01 60.14 Lymphoedema | 2 0.02 60.16 Lymphoma | 7 0.07 60.23 Lymphopenia | 4 0.04 60.27 Macular degeneration | 4 0.04 60.31 Macular hole | 3 0.03 60.34 Macular oedema | 5 0.05 60.39 Major depression | 2 0.02 60.41 Malaise | 71 0.71 61.12 Male genital atrophy | 1 0.01 61.13 Male sexual dysfunction | 1 0.01 61.14 Malignant fibrous histiocytoma | 1 0.01 61.15 Malignant melanoma | 4 0.04 61.19 Malignant melanoma stage I | 1 0.01 61.20 Malignant neoplasm of spinal cord | 1 0.01 61.21 Malignant neoplasm progression | 30 0.30 61.51 Malnutrition | 4 0.04 61.55 Mammary duct ectasia | 1 0.01 61.56 Mania | 1 0.01 61.57 Marital problem | 1 0.01 61.58 Mass | 4 0.04 61.62 Mastectomy | 1 0.01 61.63 Mastoid disorder | 1 0.01 61.64 Mastoiditis | 2 0.02 61.66 Maternal exposure during pregnancy | 8 0.08 61.74 Maternal exposure timing unspecified | 1 0.01 61.75 Medical device discomfort | 1 0.01 61.76 Medical device implantation | 1 0.01 61.77 Medical device pain | 1 0.01 61.78 Medical device removal | 7 0.07 61.85 Medical device site pain | 1 0.01 61.86 Medication crystals in urine | 1 0.01 61.87 Medication error | 3 0.03 61.90 Medication residue present | 2 0.02 61.92 Megacolon | 1 0.01 61.93 Meibomianitis | 1 0.01 61.94 Melaena | 2 0.02 61.96 Melanocytic naevus | 1 0.01 61.97 Memory impairment | 27 0.27 62.24 Meniere's disease | 1 0.01 62.25 Meningitis | 2 0.02 62.27 Meningitis bacterial | 1 0.01 62.28 Meningitis meningococcal | 1 0.01 62.29 Meningitis viral | 1 0.01 62.30 Meningococcal sepsis | 1 0.01 62.31 Meningomyelocele | 1 0.01 62.32 Meniscus injury | 5 0.05 62.37 Meniscus removal | 1 0.01 62.38 Menorrhagia | 2 0.02 62.40 Menstruation irregular | 2 0.02 62.42 Mental disorder | 11 0.11 62.53 Mental fatigue | 1 0.01 62.54 Mental impairment | 3 0.03 62.57 Mental status changes | 5 0.05 62.62 Meralgia paraesthetica | 1 0.01 62.63 Metabolic acidosis | 3 0.03 62.66 Metabolic disorder | 2 0.02 62.68 Metabolic syndrome | 1 0.01 62.69 Metastases to bone | 1 0.01 62.70 Metastases to breast | 1 0.01 62.71 Metastases to central nervous system | 2 0.02 62.73 Metastases to chest wall | 1 0.01 62.74 Metastases to liver | 3 0.03 62.77 Metastases to lung | 2 0.02 62.79 Metastases to peritoneum | 1 0.01 62.80 Metastases to pharynx | 1 0.01 62.81 Metastases to spine | 1 0.01 62.82 Metastases to thorax | 1 0.01 62.83 Metastasis | 2 0.02 62.85 Metastatic gastric cancer | 1 0.01 62.86 Metastatic neoplasm | 2 0.02 62.88 Microcytic anaemia | 1 0.01 62.89 Micturition urgency | 1 0.01 62.90 Middle insomnia | 3 0.03 62.93 Migraine | 19 0.19 63.12 Migraine with aura | 2 0.02 63.14 Mitochondrial DNA mutation | 1 0.01 63.15 Mitral valve disease mixed | 1 0.01 63.16 Mitral valve prolapse | 3 0.03 63.19 Mobility decreased | 10 0.10 63.29 Monoparesis | 1 0.01 63.30 Mood altered | 3 0.03 63.33 Mood swings | 5 0.05 63.38 Morganella infection | 1 0.01 63.39 Motor dysfunction | 1 0.01 63.40 Mouth haemorrhage | 2 0.02 63.42 Mouth swelling | 2 0.02 63.44 Mouth ulceration | 2 0.02 63.46 Movement disorder | 3 0.03 63.49 Mucormycosis | 1 0.01 63.50 Mucosal dryness | 1 0.01 63.51 Mucosal inflammation | 10 0.10 63.61 Mucous stools | 1 0.01 63.62 Multiple allergies | 2 0.02 63.64 Multiple fractures | 1 0.01 63.65 Multiple injuries | 2 0.02 63.67 Multiple organ dysfunction syndrome | 9 0.09 63.76 Multiple sclerosis | 6 0.06 63.82 Multiple sclerosis relapse | 11 0.11 63.93 Muscle atrophy | 4 0.04 63.97 Muscle contracture | 1 0.01 63.98 Muscle disorder | 2 0.02 64.00 Muscle haemorrhage | 1 0.01 64.01 Muscle operation | 1 0.01 64.02 Muscle rigidity | 3 0.03 64.05 Muscle rupture | 1 0.01 64.06 Muscle spasms | 20 0.20 64.26 Muscle strain | 6 0.06 64.32 Muscle tightness | 2 0.02 64.34 Muscle tone disorder | 1 0.01 64.35 Muscle twitching | 3 0.03 64.38 Muscular weakness | 24 0.24 64.62 Musculoskeletal chest pain | 6 0.06 64.68 Musculoskeletal discomfort | 3 0.03 64.71 Musculoskeletal disorder | 2 0.02 64.73 Musculoskeletal pain | 10 0.10 64.83 Musculoskeletal stiffness | 13 0.13 64.96 Myalgia | 23 0.23 65.19 Mycobacterium avium complex infection | 1 0.01 65.20 Mydriasis | 1 0.01 65.21 Myelodysplastic syndrome | 8 0.08 65.29 Myelodysplastic syndrome transformation | 1 0.01 65.30 Myelopathy | 1 0.01 65.31 Myocardial infarction | 35 0.35 65.66 Myocardial ischaemia | 2 0.02 65.68 Myocardial necrosis marker increased | 1 0.01 65.69 Myoglobin blood increased | 1 0.01 65.70 Myopathy | 2 0.02 65.72 Myositis | 1 0.01 65.73 N-ras gene mutation | 1 0.01 65.74 N-terminal prohormone brain natriuret.. | 1 0.01 65.75 Nail avulsion | 1 0.01 65.76 Nail discolouration | 1 0.01 65.77 Nail disorder | 3 0.03 65.80 Nasal congestion | 12 0.12 65.92 Nasal discharge discolouration | 1 0.01 65.93 Nasal discomfort | 3 0.03 65.96 Nasal disorder | 2 0.02 65.98 Nasal dryness | 1 0.01 65.99 Nasal injury | 1 0.01 66.00 Nasal obstruction | 1 0.01 66.01 Nasal polypectomy | 1 0.01 66.02 Nasal septum deviation | 1 0.01 66.03 Nasal septum ulceration | 1 0.01 66.04 Nasopharyngitis | 29 0.29 66.33 Nausea | 97 0.97 67.30 Neck pain | 7 0.07 67.37 Necrosis | 3 0.03 67.40 Needle issue | 3 0.03 67.43 Negative thoughts | 1 0.01 67.44 Neoplasm | 2 0.02 67.46 Neoplasm malignant | 11 0.11 67.57 Neoplasm progression | 4 0.04 67.61 Neoplasm recurrence | 1 0.01 67.62 Nephrocalcinosis | 1 0.01 67.63 Nephrolithiasis | 9 0.09 67.72 Nephropathy | 1 0.01 67.73 Nephropathy toxic | 1 0.01 67.74 Nephrotic syndrome | 1 0.01 67.75 Nerve compression | 2 0.02 67.77 Nerve degeneration | 1 0.01 67.78 Nerve injury | 4 0.04 67.82 Nerve root compression | 1 0.01 67.83 Nervous system disorder | 8 0.08 67.91 Nervousness | 11 0.11 68.02 Neurogenic bladder | 2 0.02 68.04 Neurologic neglect syndrome | 1 0.01 68.05 Neurological decompensation | 1 0.01 68.06 Neuroma | 2 0.02 68.08 Neuropathic arthropathy | 1 0.01 68.09 Neuropathy peripheral | 18 0.18 68.27 Neurotoxicity | 5 0.05 68.32 Neutropenia | 41 0.41 68.73 Neutropenic sepsis | 3 0.03 68.76 Neutrophil count decreased | 14 0.14 68.90 Nightmare | 5 0.05 68.95 No adverse event | 6 0.06 69.01 Nocardiosis | 1 0.01 69.02 Nocturia | 3 0.03 69.05 Nocturnal dyspnoea | 1 0.01 69.06 Nodule | 3 0.03 69.09 Non-Hodgkin's lymphoma | 4 0.04 69.13 Non-Hodgkin's lymphoma recurrent | 1 0.01 69.14 Non-alcoholic steatohepatitis | 1 0.01 69.15 Non-small cell lung cancer | 1 0.01 69.16 Normal newborn | 2 0.02 69.18 Nuchal rigidity | 1 0.01 69.19 Nystagmus | 1 0.01 69.20 Obesity | 6 0.06 69.26 Obliterative bronchiolitis | 2 0.02 69.28 Obsessive thoughts | 2 0.02 69.30 Obsessive-compulsive disorder | 2 0.02 69.32 Obstruction | 1 0.01 69.33 Occult blood | 1 0.01 69.34 Occult blood positive | 2 0.02 69.36 Occupational exposure to product | 1 0.01 69.37 Occupational exposure to toxic agent | 1 0.01 69.38 Ocular discomfort | 2 0.02 69.40 Ocular hyperaemia | 5 0.05 69.45 Ocular hypertension | 1 0.01 69.46 Ocular icterus | 1 0.01 69.47 Ocular ischaemic syndrome | 1 0.01 69.48 Ocular myasthenia | 1 0.01 69.49 Ocular vascular disorder | 1 0.01 69.50 Oculogyric crisis | 1 0.01 69.51 Oedema | 8 0.08 69.59 Oedema mouth | 2 0.02 69.61 Oedema peripheral | 18 0.18 69.79 Oesophageal atresia | 1 0.01 69.80 Oesophageal infection | 1 0.01 69.81 Oesophageal stenosis | 3 0.03 69.84 Oesophageal ulcer | 1 0.01 69.85 Oesophagitis | 5 0.05 69.90 Oestradiol increased | 1 0.01 69.91 Oestrogen deficiency | 1 0.01 69.92 Off label use | 65 0.65 70.57 Off label use of device | 1 0.01 70.58 Olfacto genital dysplasia | 1 0.01 70.59 Oligomenorrhoea | 1 0.01 70.60 Oliguria | 2 0.02 70.62 Onychoclasis | 2 0.02 70.64 Onychomadesis | 1 0.01 70.65 Onychomycosis | 2 0.02 70.67 Oophorectomy | 1 0.01 70.68 Open fracture | 1 0.01 70.69 Open reduction of fracture | 11 0.11 70.80 Ophthalmic herpes simplex | 1 0.01 70.81 Ophthalmic herpes zoster | 1 0.01 70.82 Optic ischaemic neuropathy | 1 0.01 70.83 Optic nerve disorder | 1 0.01 70.84 Optic neuritis | 2 0.02 70.86 Oral candidiasis | 3 0.03 70.89 Oral discomfort | 1 0.01 70.90 Oral herpes | 1 0.01 70.91 Oral mucosal exfoliation | 1 0.01 70.92 Oral pain | 3 0.03 70.95 Oral surgery | 2 0.02 70.97 Organ failure | 1 0.01 70.98 Organic erectile dysfunction | 3 0.03 71.01 Organising pneumonia | 1 0.01 71.02 Orgasm abnormal | 3 0.03 71.05 Orgasmic sensation decreased | 1 0.01 71.06 Oropharyngeal pain | 8 0.08 71.14 Orthopaedic procedure | 1 0.01 71.15 Orthosis user | 1 0.01 71.16 Orthostatic hypotension | 2 0.02 71.18 Osteoarthritis | 36 0.36 71.54 Osteochondrosis | 1 0.01 71.55 Osteolysis | 1 0.01 71.56 Osteomalacia | 3 0.03 71.59 Osteomyelitis | 4 0.04 71.63 Osteomyelitis chronic | 1 0.01 71.64 Osteonecrosis | 7 0.07 71.71 Osteonecrosis of jaw | 3 0.03 71.74 Osteopenia | 15 0.15 71.89 Osteoporosis | 23 0.23 72.12 Osteoporotic fracture | 1 0.01 72.13 Otitis media | 8 0.08 72.21 Otitis media chronic | 1 0.01 72.22 Ovarian cancer | 4 0.04 72.26 Ovarian cancer metastatic | 2 0.02 72.28 Ovarian cyst | 5 0.05 72.33 Ovarian neoplasm | 1 0.01 72.34 Overdose | 19 0.19 72.53 Overweight | 1 0.01 72.54 Oxygen saturation decreased | 3 0.03 72.57 Oxygen supplementation | 1 0.01 72.58 Pain | 67 0.67 73.25 Pain in extremity | 56 0.56 73.81 Pain in jaw | 7 0.07 73.88 Pain of skin | 2 0.02 73.90 Pallor | 1 0.01 73.91 Palmar-plantar erythrodysaesthesia sy.. | 5 0.05 73.96 Palpitations | 13 0.13 74.09 Pancreas infection | 1 0.01 74.10 Pancreatic calcification | 1 0.01 74.11 Pancreatic carcinoma | 3 0.03 74.14 Pancreatic carcinoma metastatic | 1 0.01 74.15 Pancreatic carcinoma recurrent | 1 0.01 74.16 Pancreatic cyst | 2 0.02 74.18 Pancreatic disorder | 1 0.01 74.19 Pancreatic injury | 1 0.01 74.20 Pancreatic necrosis | 1 0.01 74.21 Pancreatic neoplasm | 2 0.02 74.23 Pancreatic neuroendocrine tumour meta.. | 1 0.01 74.24 Pancreatitis | 7 0.07 74.31 Pancreatitis acute | 5 0.05 74.36 Pancreatitis chronic | 2 0.02 74.38 Pancytopenia | 15 0.15 74.53 Panic attack | 7 0.07 74.60 Panic disorder | 1 0.01 74.61 Panic reaction | 1 0.01 74.62 Papillary thyroid cancer | 1 0.01 74.63 Papilloma viral infection | 1 0.01 74.64 Paradoxical drug reaction | 1 0.01 74.65 Paraesthesia | 18 0.18 74.83 Paranasal sinus discomfort | 2 0.02 74.85 Paranasal sinus haematoma | 1 0.01 74.86 Paranasal sinus hypersecretion | 1 0.01 74.87 Paranoia | 2 0.02 74.89 Paraplegia | 1 0.01 74.90 Parathyroid disorder | 2 0.02 74.92 Parkinson's disease | 2 0.02 74.94 Parkinsonism | 2 0.02 74.96 Paronychia | 1 0.01 74.97 Parophthalmia | 1 0.01 74.98 Patellofemoral pain syndrome | 1 0.01 74.99 Patent ductus arteriosus | 2 0.02 75.01 Pathological fracture | 5 0.05 75.06 Patient dissatisfaction with treatment | 1 0.01 75.07 Pectus excavatum | 1 0.01 75.08 Pelvic abscess | 1 0.01 75.09 Pelvic adhesions | 1 0.01 75.10 Pelvic fracture | 2 0.02 75.12 Pelvic pain | 4 0.04 75.16 Pemphigoid | 1 0.01 75.17 Pemphigus | 2 0.02 75.19 Penile blister | 1 0.01 75.20 Penile pain | 1 0.01 75.21 Penile plaque | 1 0.01 75.22 Penile size reduced | 3 0.03 75.25 Penis injury | 3 0.03 75.28 Perforation | 1 0.01 75.29 Periarthritis | 2 0.02 75.31 Pericardial effusion | 2 0.02 75.33 Pericarditis | 7 0.07 75.40 Periostitis | 1 0.01 75.41 Peripheral arterial occlusive disease | 4 0.04 75.45 Peripheral artery thrombosis | 1 0.01 75.46 Peripheral arthritis | 1 0.01 75.47 Peripheral coldness | 1 0.01 75.48 Peripheral ischaemia | 1 0.01 75.49 Peripheral motor neuropathy | 3 0.03 75.52 Peripheral sensory neuropathy | 7 0.07 75.59 Peripheral swelling | 20 0.20 75.79 Peripheral vascular disorder | 5 0.05 75.84 Periprosthetic fracture | 1 0.01 75.85 Peritoneal disorder | 1 0.01 75.86 Peritoneal haemorrhage | 1 0.01 75.87 Peritoneal perforation | 1 0.01 75.88 Peritonitis | 6 0.06 75.94 Peritonsillar abscess | 1 0.01 75.95 Peroneal nerve palsy | 3 0.03 75.98 Perseveration | 1 0.01 75.99 Persistent depressive disorder | 1 0.01 76.00 Persistent foetal circulation | 2 0.02 76.02 Personality change | 5 0.05 76.07 Petechiae | 1 0.01 76.08 Petit mal epilepsy | 1 0.01 76.09 Peyronie's disease | 2 0.02 76.11 Pharyngeal abscess | 1 0.01 76.12 Pharyngeal disorder | 2 0.02 76.14 Pharyngeal erythema | 1 0.01 76.15 Pharyngeal neoplasm | 1 0.01 76.16 Pharyngeal oedema | 3 0.03 76.19 Pharyngitis | 9 0.09 76.28 Pharyngitis streptococcal | 3 0.03 76.31 Phlebitis | 1 0.01 76.32 Phobia | 2 0.02 76.34 Photophobia | 3 0.03 76.37 Photopsia | 3 0.03 76.40 Photosensitivity reaction | 1 0.01 76.41 Pigmentation disorder | 1 0.01 76.42 Pituitary tumour | 2 0.02 76.44 Pityriasis | 1 0.01 76.45 Placental insufficiency | 2 0.02 76.47 Plantar fasciitis | 2 0.02 76.49 Plasma cell myeloma | 6 0.06 76.55 Platelet count decreased | 30 0.30 76.85 Platelet count increased | 1 0.01 76.86 Platelet disorder | 1 0.01 76.87 Platelet transfusion | 1 0.01 76.88 Pleural effusion | 13 0.13 77.01 Pleurisy | 2 0.02 77.03 Pleurisy viral | 1 0.01 77.04 Pneumatosis intestinalis | 1 0.01 77.05 Pneumobilia | 1 0.01 77.06 Pneumococcal sepsis | 1 0.01 77.07 Pneumocystis jirovecii pneumonia | 3 0.03 77.10 Pneumomediastinum | 1 0.01 77.11 Pneumonia | 86 0.86 77.97 Pneumonia aspiration | 7 0.07 78.04 Pneumonia bacterial | 2 0.02 78.06 Pneumonia influenzal | 1 0.01 78.07 Pneumonia pneumococcal | 1 0.01 78.08 Pneumonitis | 6 0.06 78.14 Pneumothorax | 6 0.06 78.20 Poisoning | 2 0.02 78.22 Pollakiuria | 5 0.05 78.27 Polyarthritis | 3 0.03 78.30 Polychondritis | 1 0.01 78.31 Polymyalgia rheumatica | 1 0.01 78.32 Polymyositis | 4 0.04 78.36 Polyneuropathy | 2 0.02 78.38 Polyp | 1 0.01 78.39 Polyuria | 1 0.01 78.40 Poor peripheral circulation | 4 0.04 78.44 Poor quality sleep | 3 0.03 78.47 Poor venous access | 2 0.02 78.49 Popliteal pulse decreased | 1 0.01 78.50 Post concussion syndrome | 1 0.01 78.51 Post herpetic neuralgia | 1 0.01 78.52 Post procedural cellulitis | 1 0.01 78.53 Post procedural complication | 1 0.01 78.54 Post procedural discomfort | 1 0.01 78.55 Post procedural haematoma | 1 0.01 78.56 Post procedural haemorrhage | 1 0.01 78.57 Post procedural infection | 1 0.01 78.58 Post-traumatic headache | 1 0.01 78.59 Post-traumatic neck syndrome | 1 0.01 78.60 Post-traumatic stress disorder | 1 0.01 78.61 Postoperative adhesion | 1 0.01 78.62 Postoperative fever | 1 0.01 78.63 Postoperative ileus | 1 0.01 78.64 Postoperative respiratory distress | 1 0.01 78.65 Postoperative respiratory failure | 2 0.02 78.67 Postoperative wound infection | 1 0.01 78.68 Posture abnormal | 1 0.01 78.69 Pouchitis | 1 0.01 78.70 Pre-eclampsia | 1 0.01 78.71 Pre-existing condition improved | 1 0.01 78.72 Precancerous skin lesion | 1 0.01 78.73 Pregnancy | 4 0.04 78.77 Premature baby | 3 0.03 78.80 Premature delivery | 2 0.02 78.82 Premature ejaculation | 2 0.02 78.84 Premature labour | 2 0.02 78.86 Premature separation of placenta | 1 0.01 78.87 Prescribed overdose | 2 0.02 78.89 Prescribed underdose | 3 0.03 78.92 Presyncope | 4 0.04 78.96 Priapism | 1 0.01 78.97 Procedural complication | 2 0.02 78.99 Procedural hypotension | 1 0.01 79.00 Procedural nausea | 2 0.02 79.02 Procedural pain | 1 0.01 79.03 Procedural vomiting | 2 0.02 79.05 Proctalgia | 1 0.01 79.06 Product adhesion issue | 1 0.01 79.07 Product closure removal difficult | 1 0.01 79.08 Product contamination microbial | 1 0.01 79.09 Product counterfeit | 2 0.02 79.11 Product label issue | 1 0.01 79.12 Product packaging issue | 1 0.01 79.13 Product packaging quantity issue | 1 0.01 79.14 Product physical issue | 1 0.01 79.15 Product quality issue | 24 0.24 79.39 Product reconstitution issue | 1 0.01 79.40 Product substitution issue | 4 0.04 79.44 Product use issue | 44 0.44 79.88 Productive cough | 11 0.11 79.99 Progressive multifocal leukoencephalo.. | 8 0.08 80.07 Propofol infusion syndrome | 1 0.01 80.08 Prostate cancer | 4 0.04 80.12 Prostatic disorder | 1 0.01 80.13 Prostatic pain | 1 0.01 80.14 Prostatic specific antigen increased | 1 0.01 80.15 Prostatitis | 3 0.03 80.18 Prostatomegaly | 1 0.01 80.19 Protein urine present | 1 0.01 80.20 Proteinuria | 3 0.03 80.23 Prothrombin level increased | 1 0.01 80.24 Prothrombin time ratio increased | 1 0.01 80.25 Pruritus | 29 0.29 80.54 Pruritus generalised | 3 0.03 80.57 Pseudarthrosis | 1 0.01 80.58 Pseudoendophthalmitis | 1 0.01 80.59 Pseudomembranous colitis | 3 0.03 80.62 Pseudomonas infection | 1 0.01 80.63 Pseudoporphyria | 1 0.01 80.64 Psoriasis | 8 0.08 80.72 Psoriatic arthropathy | 2 0.02 80.74 Psychiatric symptom | 1 0.01 80.75 Psychomotor hyperactivity | 1 0.01 80.76 Psychomotor retardation | 1 0.01 80.77 Psychomotor skills impaired | 1 0.01 80.78 Psychotic disorder | 6 0.06 80.84 Pubis fracture | 4 0.04 80.88 Pulmonary alveolar haemorrhage | 2 0.02 80.90 Pulmonary arterial hypertension | 6 0.06 80.96 Pulmonary arterial pressure increased | 1 0.01 80.97 Pulmonary congestion | 2 0.02 80.99 Pulmonary embolism | 19 0.19 81.18 Pulmonary fibrosis | 3 0.03 81.21 Pulmonary function test abnormal | 1 0.01 81.22 Pulmonary function test decreased | 2 0.02 81.24 Pulmonary hypertension | 1 0.01 81.25 Pulmonary mass | 7 0.07 81.32 Pulmonary oedema | 12 0.12 81.44 Pulmonary resection | 1 0.01 81.45 Pulmonary thrombosis | 1 0.01 81.46 Pulmonary tuberculosis | 2 0.02 81.48 Pulmonary vascular disorder | 1 0.01 81.49 Pulmonary vein occlusion | 1 0.01 81.50 Pulpitis dental | 1 0.01 81.51 Pulse abnormal | 1 0.01 81.52 Pulseless electrical activity | 1 0.01 81.53 Pupils unequal | 2 0.02 81.55 Purpura | 1 0.01 81.56 Purulent discharge | 1 0.01 81.57 Pustular psoriasis | 1 0.01 81.58 Putamen haemorrhage | 1 0.01 81.59 Pyelonephritis | 3 0.03 81.62 Pyelonephritis acute | 1 0.01 81.63 Pyrexia | 51 0.51 82.14 QRS axis abnormal | 1 0.01 82.15 Radial nerve palsy | 2 0.02 82.17 Radiation pneumonitis | 2 0.02 82.19 Radiculopathy | 3 0.03 82.22 Radius fracture | 7 0.07 82.29 Rash | 31 0.31 82.60 Rash erythematous | 2 0.02 82.62 Rash generalised | 1 0.01 82.63 Rash macular | 2 0.02 82.65 Rash maculo-papular | 3 0.03 82.68 Rash papular | 2 0.02 82.70 Rash pruritic | 2 0.02 82.72 Raynaud's phenomenon | 2 0.02 82.74 Rectal abscess | 2 0.02 82.76 Rectal adenocarcinoma | 1 0.01 82.77 Rectal cancer | 1 0.01 82.78 Rectal discharge | 1 0.01 82.79 Rectal fissure | 1 0.01 82.80 Rectal haemorrhage | 11 0.11 82.91 Rectal prolapse | 1 0.01 82.92 Red blood cell count decreased | 6 0.06 82.98 Red blood cell sedimentation rate inc.. | 1 0.01 82.99 Regurgitation | 2 0.02 83.01 Removal of internal fixation | 1 0.01 83.02 Renal abscess | 1 0.01 83.03 Renal artery occlusion | 1 0.01 83.04 Renal artery stenosis | 1 0.01 83.05 Renal atrophy | 1 0.01 83.06 Renal cell carcinoma | 1 0.01 83.07 Renal cyst | 3 0.03 83.10 Renal disorder | 7 0.07 83.17 Renal failure | 30 0.30 83.47 Renal function test abnormal | 2 0.02 83.49 Renal impairment | 14 0.14 83.63 Renal injury | 1 0.01 83.64 Renal pain | 2 0.02 83.66 Renal scan abnormal | 1 0.01 83.67 Renal transplant failure | 1 0.01 83.68 Renal tubular acidosis | 1 0.01 83.69 Renal tubular dysfunction | 1 0.01 83.70 Renal tubular necrosis | 2 0.02 83.72 Renin increased | 1 0.01 83.73 Reproductive tract disorder | 1 0.01 83.74 Respiratory arrest | 5 0.05 83.79 Respiratory disorder | 3 0.03 83.82 Respiratory distress | 1 0.01 83.83 Respiratory failure | 9 0.09 83.92 Respiratory tract congestion | 1 0.01 83.93 Respiratory tract infection | 3 0.03 83.96 Respiratory tract infection viral | 1 0.01 83.97 Restless legs syndrome | 4 0.04 84.01 Restlessness | 7 0.07 84.08 Retching | 3 0.03 84.11 Reticulocyte count increased | 1 0.01 84.12 Retinal detachment | 3 0.03 84.15 Retinal disorder | 1 0.01 84.16 Retinal haemorrhage | 1 0.01 84.17 Retinal pigment epithelial tear | 1 0.01 84.18 Retinal tear | 1 0.01 84.19 Retinal vascular occlusion | 1 0.01 84.20 Retinopathy | 1 0.01 84.21 Retroperitoneal hernia | 1 0.01 84.22 Retroperitoneal neoplasm | 1 0.01 84.23 Rhabdomyolysis | 5 0.05 84.28 Rheumatic disorder | 2 0.02 84.30 Rheumatoid arthritis | 21 0.21 84.51 Rheumatoid factor increased | 1 0.01 84.52 Rheumatoid nodule | 2 0.02 84.54 Rheumatoid vasculitis | 1 0.01 84.55 Rhinitis | 3 0.03 84.58 Rhinitis allergic | 9 0.09 84.67 Rhinorrhoea | 6 0.06 84.73 Rib fracture | 8 0.08 84.81 Richter's syndrome | 1 0.01 84.82 Right ventricular failure | 5 0.05 84.87 Road traffic accident | 10 0.10 84.97 Rosacea | 3 0.03 85.00 Rotator cuff repair | 2 0.02 85.02 Rotator cuff syndrome | 8 0.08 85.10 Rubber sensitivity | 1 0.01 85.11 Salt craving | 1 0.01 85.12 Scapula fracture | 1 0.01 85.13 Scar | 3 0.03 85.16 Scar excision | 1 0.01 85.17 Schizophrenia | 2 0.02 85.19 Sciatica | 9 0.09 85.28 Scoliosis | 12 0.12 85.40 Scratch | 1 0.01 85.41 Scrotal disorder | 1 0.01 85.42 Scrotal varicose veins | 1 0.01 85.43 Seasonal allergy | 3 0.03 85.46 Sebaceous naevus | 1 0.01 85.47 Seborrhoeic dermatitis | 1 0.01 85.48 Seborrhoeic keratosis | 2 0.02 85.50 Second primary malignancy | 6 0.06 85.56 Secondary hypogonadism | 2 0.02 85.58 Sedation | 1 0.01 85.59 Seizure | 24 0.24 85.83 Self esteem decreased | 3 0.03 85.86 Self-medication | 1 0.01 85.87 Semen volume decreased | 7 0.07 85.94 Sensation of foreign body | 2 0.02 85.96 Sense of oppression | 1 0.01 85.97 Sensitivity to weather change | 1 0.01 85.98 Sensory disturbance | 4 0.04 86.02 Sensory loss | 2 0.02 86.04 Sepsis | 43 0.43 86.47 Septic shock | 13 0.13 86.60 Serratia sepsis | 1 0.01 86.61 Serum ferritin increased | 1 0.01 86.62 Sexual dysfunction | 29 0.29 86.91 Shock | 4 0.04 86.95 Shock haemorrhagic | 3 0.03 86.98 Shoulder operation | 1 0.01 86.99 Sialoadenitis | 1 0.01 87.00 Sickle cell anaemia | 1 0.01 87.01 Sickle cell anaemia with crisis | 1 0.01 87.02 Sinus bradycardia | 1 0.01 87.03 Sinus congestion | 6 0.06 87.09 Sinus disorder | 4 0.04 87.13 Sinus headache | 1 0.01 87.14 Sinus operation | 1 0.01 87.15 Sinus pain | 2 0.02 87.17 Sinus tachycardia | 1 0.01 87.18 Sinus tarsi syndrome | 1 0.01 87.19 Sinusitis | 25 0.25 87.44 Sjogren's syndrome | 4 0.04 87.48 Skeletal traction | 1 0.01 87.49 Skin abrasion | 3 0.03 87.52 Skin atrophy | 1 0.01 87.53 Skin bacterial infection | 1 0.01 87.54 Skin burning sensation | 1 0.01 87.55 Skin cancer | 6 0.06 87.61 Skin depigmentation | 1 0.01 87.62 Skin discolouration | 6 0.06 87.68 Skin disorder | 8 0.08 87.76 Skin exfoliation | 3 0.03 87.79 Skin fragility | 1 0.01 87.80 Skin graft | 1 0.01 87.81 Skin infection | 3 0.03 87.84 Skin irritation | 3 0.03 87.87 Skin lesion | 3 0.03 87.90 Skin mass | 1 0.01 87.91 Skin necrosis | 1 0.01 87.92 Skin neoplasm excision | 2 0.02 87.94 Skin papilloma | 1 0.01 87.95 Skin reaction | 2 0.02 87.97 Skin striae | 1 0.01 87.98 Skin toxicity | 1 0.01 87.99 Skin ulcer | 5 0.05 88.04 Skin wound | 1 0.01 88.05 Sleep apnoea syndrome | 15 0.15 88.20 Sleep disorder | 7 0.07 88.27 Sleep phase rhythm disturbance | 1 0.01 88.28 Slow response to stimuli | 1 0.01 88.29 Sluggishness | 7 0.07 88.36 Small cell lung cancer metastatic | 1 0.01 88.37 Small intestinal haemorrhage | 2 0.02 88.39 Small intestinal obstruction | 3 0.03 88.42 Small intestinal perforation | 1 0.01 88.43 Small intestine carcinoma | 1 0.01 88.44 Snoring | 1 0.01 88.45 Social avoidant behaviour | 2 0.02 88.47 Soft tissue disorder | 1 0.01 88.48 Soft tissue haemorrhage | 1 0.01 88.49 Soft tissue infection | 1 0.01 88.50 Somatic symptom disorder | 1 0.01 88.51 Somnolence | 24 0.24 88.75 Sopor | 1 0.01 88.76 Speech disorder | 16 0.16 88.92 Spina bifida | 1 0.01 88.93 Spinal column injury | 1 0.01 88.94 Spinal column stenosis | 6 0.06 89.00 Spinal compression fracture | 8 0.08 89.08 Spinal cord compression | 1 0.01 89.09 Spinal cord neoplasm | 1 0.01 89.10 Spinal decompression | 1 0.01 89.11 Spinal deformity | 2 0.02 89.13 Spinal disorder | 2 0.02 89.15 Spinal epidural haematoma | 1 0.01 89.16 Spinal fracture | 5 0.05 89.21 Spinal laminectomy | 1 0.01 89.22 Spinal osteoarthritis | 13 0.13 89.35 Spinal pain | 3 0.03 89.38 Spine malformation | 1 0.01 89.39 Splenic abscess | 1 0.01 89.40 Splenomegaly | 4 0.04 89.44 Spondylolisthesis | 7 0.07 89.51 Spondylolysis | 1 0.01 89.52 Sputum discoloured | 1 0.01 89.53 Sputum increased | 2 0.02 89.55 Squamous cell carcinoma | 3 0.03 89.58 Squamous cell carcinoma of skin | 1 0.01 89.59 Stapedectomy | 1 0.01 89.60 Staphylococcal bacteraemia | 2 0.02 89.62 Staphylococcal infection | 4 0.04 89.66 Staphylococcal sepsis | 3 0.03 89.69 Staring | 1 0.01 89.70 Status epilepticus | 2 0.02 89.72 Steatorrhoea | 1 0.01 89.73 Stenosis | 1 0.01 89.74 Steroid withdrawal syndrome | 1 0.01 89.75 Stiff person syndrome | 1 0.01 89.76 Stillbirth | 2 0.02 89.78 Stitch abscess | 1 0.01 89.79 Stomatitis | 13 0.13 89.92 Streptococcal infection | 1 0.01 89.93 Streptococcal urinary tract infection | 1 0.01 89.94 Stress | 13 0.13 90.07 Stress at work | 1 0.01 90.08 Stress cardiomyopathy | 3 0.03 90.11 Stress fracture | 10 0.10 90.21 Stress ulcer | 1 0.01 90.22 Stress urinary incontinence | 2 0.02 90.24 Stridor | 1 0.01 90.25 Subarachnoid haemorrhage | 4 0.04 90.29 Subcutaneous abscess | 3 0.03 90.32 Subdural haematoma | 3 0.03 90.35 Subretinal fluid | 1 0.01 90.36 Sudden death | 3 0.03 90.39 Sudden onset of sleep | 1 0.01 90.40 Suffocation feeling | 1 0.01 90.41 Suicidal behaviour | 1 0.01 90.42 Suicidal ideation | 17 0.17 90.59 Suicide attempt | 4 0.04 90.63 Sunburn | 1 0.01 90.64 Supraventricular extrasystoles | 2 0.02 90.66 Supraventricular tachycardia | 1 0.01 90.67 Surgery | 3 0.03 90.70 Suspected counterfeit product | 2 0.02 90.72 Suspected transmission of an infectio.. | 1 0.01 90.73 Swelling | 4 0.04 90.77 Swelling face | 8 0.08 90.85 Swollen tongue | 3 0.03 90.88 Syncope | 14 0.14 91.02 Synovial cyst | 7 0.07 91.09 Systemic candida | 1 0.01 91.10 Systemic inflammatory response syndrome | 1 0.01 91.11 Systemic lupus erythematosus | 5 0.05 91.16 Tachycardia | 5 0.05 91.21 Tachyphrenia | 1 0.01 91.22 Talipes | 2 0.02 91.24 Telangiectasia | 1 0.01 91.25 Temperature intolerance | 1 0.01 91.26 Temporomandibular joint syndrome | 2 0.02 91.28 Tenderness | 2 0.02 91.30 Tendon discomfort | 1 0.01 91.31 Tendon disorder | 3 0.03 91.34 Tendon injury | 1 0.01 91.35 Tendon operation | 1 0.01 91.36 Tendon rupture | 4 0.04 91.40 Tendonitis | 3 0.03 91.43 Tenoplasty | 1 0.01 91.44 Tenosynovitis | 1 0.01 91.45 Tension | 2 0.02 91.47 Tension headache | 1 0.01 91.48 Terminal dribbling | 2 0.02 91.50 Testicular atrophy | 4 0.04 91.54 Testicular disorder | 2 0.02 91.56 Testicular failure | 1 0.01 91.57 Testicular injury | 1 0.01 91.58 Testicular mass | 1 0.01 91.59 Testicular pain | 7 0.07 91.66 Testicular seminoma (pure) stage I | 1 0.01 91.67 Theft | 1 0.01 91.68 Therapeutic response decreased | 8 0.08 91.76 Therapeutic response unexpected | 2 0.02 91.78 Therapy cessation | 1 0.01 91.79 Therapy non-responder | 7 0.07 91.86 Therapy partial responder | 1 0.01 91.87 Thermal burn | 1 0.01 91.88 Thinking abnormal | 4 0.04 91.92 Thirst | 2 0.02 91.94 Thoracic operation | 2 0.02 91.96 Thoracic vertebral fracture | 2 0.02 91.98 Throat cancer | 1 0.01 91.99 Throat irritation | 10 0.10 92.09 Throat tightness | 5 0.05 92.14 Thrombocytopenia | 40 0.40 92.54 Thrombocytosis | 1 0.01 92.55 Thrombophlebitis | 3 0.03 92.58 Thrombosis | 18 0.18 92.76 Thrombotic microangiopathy | 4 0.04 92.80 Thrombotic thrombocytopenic purpura | 1 0.01 92.81 Thyroid atrophy | 1 0.01 92.82 Thyroid cancer | 1 0.01 92.83 Thyroid cancer metastatic | 1 0.01 92.84 Thyroid disorder | 5 0.05 92.89 Thyroid mass | 1 0.01 92.90 Thyrotoxic crisis | 1 0.01 92.91 Tibia fracture | 5 0.05 92.96 Tinea cruris | 1 0.01 92.97 Tinnitus | 7 0.07 93.04 Toe amputation | 1 0.01 93.05 Toe operation | 1 0.01 93.06 Tongue discolouration | 1 0.01 93.07 Tongue discomfort | 2 0.02 93.09 Tongue disorder | 1 0.01 93.10 Tonsillar disorder | 2 0.02 93.12 Tonsillar hypertrophy | 1 0.01 93.13 Tonsillectomy | 2 0.02 93.15 Tooth disorder | 12 0.12 93.27 Tooth extraction | 5 0.05 93.32 Tooth fracture | 4 0.04 93.36 Tooth infection | 1 0.01 93.37 Tooth loss | 2 0.02 93.39 Toothache | 1 0.01 93.40 Torticollis | 1 0.01 93.41 Toxic epidermal necrolysis | 1 0.01 93.42 Toxic shock syndrome | 1 0.01 93.43 Toxic skin eruption | 2 0.02 93.45 Toxicity to various agents | 17 0.17 93.62 Toxoplasmosis | 1 0.01 93.63 Transaminases increased | 5 0.05 93.68 Transfusion | 1 0.01 93.69 Transient ischaemic attack | 7 0.07 93.76 Transplant | 1 0.01 93.77 Transplant failure | 1 0.01 93.78 Transplant rejection | 2 0.02 93.80 Transposition of the great vessels | 1 0.01 93.81 Traumatic haematoma | 1 0.01 93.82 Traumatic shock | 1 0.01 93.83 Treatment failure | 4 0.04 93.87 Treatment noncompliance | 1 0.01 93.88 Tremor | 17 0.17 94.05 Tri-iodothyronine increased | 1 0.01 94.06 Trichophytic granuloma | 1 0.01 94.07 Tricuspid valve incompetence | 2 0.02 94.09 Trigger finger | 3 0.03 94.12 Tuberculin test positive | 1 0.01 94.13 Tuberculosis | 2 0.02 94.15 Tubulointerstitial nephritis | 1 0.01 94.16 Tumour excision | 1 0.01 94.17 Tumour flare | 1 0.01 94.18 Tumour haemorrhage | 2 0.02 94.20 Tumour lysis syndrome | 3 0.03 94.23 Tumour marker increased | 1 0.01 94.24 Tumour necrosis | 1 0.01 94.25 Tumour ulceration | 1 0.01 94.26 Tympanic membrane disorder | 1 0.01 94.27 Type 2 diabetes mellitus | 5 0.05 94.32 Ulcer | 3 0.03 94.35 Ulcer haemorrhage | 2 0.02 94.37 Ulcerative gastritis | 1 0.01 94.38 Ulna fracture | 2 0.02 94.40 Ulnar nerve injury | 1 0.01 94.41 Ulnar nerve palsy | 1 0.01 94.42 Umbilical hernia | 1 0.01 94.43 Umbilical hernia, obstructive | 1 0.01 94.44 Underdose | 3 0.03 94.47 Unevaluable event | 6 0.06 94.53 Unresponsive to stimuli | 3 0.03 94.56 Upper gastrointestinal haemorrhage | 3 0.03 94.59 Upper limb fracture | 6 0.06 94.65 Upper respiratory tract infection | 12 0.12 94.77 Upper respiratory tract inflammation | 2 0.02 94.79 Upper-airway cough syndrome | 1 0.01 94.80 Urethral dilatation | 1 0.01 94.81 Urge incontinence | 1 0.01 94.82 Urinary incontinence | 5 0.05 94.87 Urinary retention | 8 0.08 94.95 Urinary retention postoperative | 2 0.02 94.97 Urinary tract disorder | 2 0.02 94.99 Urinary tract infection | 38 0.38 95.37 Urinary tract infection bacterial | 3 0.03 95.40 Urinary tract infection enterococcal | 1 0.01 95.41 Urinary tract obstruction | 3 0.03 95.44 Urine analysis abnormal | 3 0.03 95.47 Urine flow decreased | 1 0.01 95.48 Urine output decreased | 2 0.02 95.50 Urosepsis | 1 0.01 95.51 Urticaria | 13 0.13 95.64 Uterine cancer | 3 0.03 95.67 Uterine disorder | 2 0.02 95.69 Uterine leiomyoma | 1 0.01 95.70 Uterine perforation | 1 0.01 95.71 Uterine polyp | 1 0.01 95.72 Uterine prolapse | 1 0.01 95.73 Uveitis | 4 0.04 95.77 Vaginal cyst | 1 0.01 95.78 Vaginal haemorrhage | 6 0.06 95.84 Vaginal infection | 1 0.01 95.85 Varicella zoster virus infection | 1 0.01 95.86 Varices oesophageal | 3 0.03 95.89 Varicocele | 2 0.02 95.91 Varicose vein | 3 0.03 95.94 Varicose vein operation | 1 0.01 95.95 Vascular access complication | 2 0.02 95.97 Vascular calcification | 2 0.02 95.99 Vascular compression | 1 0.01 96.00 Vascular graft | 1 0.01 96.01 Vascular malformation | 1 0.01 96.02 Vascular pseudoaneurysm ruptured | 1 0.01 96.03 Vascular rupture | 1 0.01 96.04 Vasculitis | 2 0.02 96.06 Vasculitis cerebral | 1 0.01 96.07 Vasectomy | 1 0.01 96.08 Vasodilatation | 1 0.01 96.09 Vasodilation procedure | 1 0.01 96.10 Vasospasm | 1 0.01 96.11 Vein disorder | 2 0.02 96.13 Venoocclusive liver disease | 2 0.02 96.15 Venous thrombosis | 1 0.01 96.16 Venous thrombosis limb | 1 0.01 96.17 Ventricular extrasystoles | 2 0.02 96.19 Ventricular fibrillation | 2 0.02 96.21 Ventricular hypokinesia | 1 0.01 96.22 Ventricular septal defect | 1 0.01 96.23 Ventricular tachycardia | 2 0.02 96.25 Vertebral foraminal stenosis | 3 0.03 96.28 Vertebroplasty | 2 0.02 96.30 Vertigo | 13 0.13 96.43 Vertigo labyrinthine | 1 0.01 96.44 Vertigo positional | 1 0.01 96.45 Vesicoureteral reflux surgery | 1 0.01 96.46 Viraemia | 1 0.01 96.47 Viral infection | 7 0.07 96.54 Viral mutation identified | 1 0.01 96.55 Viral upper respiratory tract infection | 1 0.01 96.56 Virologic failure | 1 0.01 96.57 Visceral congestion | 1 0.01 96.58 Vision blurred | 11 0.11 96.69 Visual acuity reduced | 7 0.07 96.76 Visual field defect | 1 0.01 96.77 Visual impairment | 12 0.12 96.89 Vitamin B12 deficiency | 3 0.03 96.92 Vitamin C deficiency | 1 0.01 96.93 Vitamin D abnormal | 1 0.01 96.94 Vitamin D decreased | 2 0.02 96.96 Vitamin D deficiency | 11 0.11 97.07 Vitreous detachment | 1 0.01 97.08 Vitreous disorder | 1 0.01 97.09 Vitreous floaters | 2 0.02 97.11 Vitreous haemorrhage | 2 0.02 97.13 Vocal cord disorder | 1 0.01 97.14 Vocal cord leukoplakia | 1 0.01 97.15 Vocal cord paralysis | 1 0.01 97.16 Vomiting | 75 0.75 97.91 Walking aid user | 1 0.01 97.92 Weight decreased | 59 0.59 98.51 Weight fluctuation | 1 0.01 98.52 Weight increased | 47 0.47 98.99 Weight loss diet | 1 0.01 99.00 Wheelchair user | 1 0.01 99.01 Wheezing | 10 0.10 99.11 White blood cell count decreased | 31 0.31 99.42 White blood cell count increased | 3 0.03 99.45 Wisdom teeth removal | 1 0.01 99.46 Withdrawal syndrome | 5 0.05 99.51 Wound | 3 0.03 99.54 Wound complication | 7 0.07 99.61 Wound dehiscence | 1 0.01 99.62 Wound haematoma | 1 0.01 99.63 Wound haemorrhage | 1 0.01 99.64 Wound infection | 3 0.03 99.67 Wound infection pseudomonas | 2 0.02 99.69 Wound secretion | 2 0.02 99.71 Wound treatment | 1 0.01 99.72 Wrist fracture | 8 0.08 99.80 Wrong drug administered | 1 0.01 99.81 Wrong technique in product usage proc.. | 16 0.16 99.97 X-ray gastrointestinal tract abnormal | 1 0.01 99.98 Xanthoma | 1 0.01 99.99 Yellow skin | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Sep 2017